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SUMMARY 
Malaria is a parasitic infection caused by a protozoan parasite of the genus Plasmodium, 
which undergoes a complex multistage developmental cycle that aUernates between a 
vertebrate and an invertebrate vector host, the female anopheles mosquito. Despite the 
continuous efforts and major eradication programmes of WHO, malaria still remains one of 
the major world heatlh problems and the greatest killer of mankind particularly in the tropical 
and subtropical regions of the world. For a brief period in early 1960s it appeared that malaria 
might soon be brought under control. Extensive spraying of dichlorodiphenyl trichloroethane 
(DDT) greatly helped in reducing anopheline mosquito population while effective 
chemotherapeutic measures were equally successful in controlling the disease. A few novel 
drugs such as chloroquine and mefloquine were successfully used for treating the patients. 
But ten years later by the mid 1970s with the resurgence of malaria, the situation was entirely 
different, the chlorinated insecticides, such as DDT, were proving to be ineffective due to a 
newly acquired phenomenon, the insecticidal resistance in mosquitoes and a more alarming 
situation has arisen due to acquired resistance in Plasmodium falciparum to various anti-
malarial drugs. Currently this constitutes the most important threat towards our efforts for 
effective control of the disease. Chloroquine and multiple drug resistant strains of P. 
faicipanim are spreading in various regions of the world including India. So in view of this 
grim situation it seems that the repertoire of tools and methods available for malaria control 
are not keeping pace with the increasing complexity of the disease over the last three decades. 
The failure ofthe conventional measures to control and eradicate malaria has led the scientists 
and research organisations to the revival of their interest in malaria research not only for finding 
the better chemotherapeutic measures but also towards finding an immunological solution to the 
disease. The development of malaria vaccine and the better immunodiagnostic methods still remain 
the two main objectives ofthe scientific working groups ofthe WHO on immunology of malaria 
since it was set up in 1976. Although, significant advances havebeenmadeindevelopingthe vaccine 
against different developmental stages ofthe malarial parasites viz. sporozoite stage, asexual blood 
stages as well as ganietocyte slagcs,the slow progress ofthe malaria vaccine development may be 
attributed to the complex multistage developmental cycle ofthe parasite and the nature of its 
interaction with its host as well as lack of suitable animal model for human malaria parasites. 
As the morbidity, its clinical symptoms and mortality due to malaria is mainly caused 
by the asexual blood stages, therefore,the blood stages of malaria parasite remains the main 
focus of malaria research not only for developing the new antimalarial drugs but also for 
developing the antimalarial vaccine, as well as for immunodiagnostic test. The biological and 
morphological similarities between human and nonhuman primate malarias make the later 
good animal model for human malaria providing suitable laboratory host available. Therefore 
the proposed study reported in this thesis deals with the immunochemical studies on asexual 
blood stages of primate malaria parasites, P. knowlesi (a simian malaria parasite) and P. 
falciparum (the most dreaded of human malaria), in order to identify the common or cross 
reactive antigens between these two parasites. So the information obtained from the 
proposed study may be useful and may further be explored for developing better 
immunodiagnostic test and immunoprophylactic measures of human malaria. 
The studies were initiated with the purification of P. knowlesi schizont infected RBCs 
(SI-RBCs), which were purified more than 95% (free from platelets and leucocytes) using 
CF-11 cellulose and glass beads column followed by one step percoll gradient (56%) 
centrifugation. The purified SI-RBCs were found to be intact and completely free from 
broken SI-RBCs, free parasites, membranes and the early infected erythrocytes. These 
purified P. knowlesi SI-RBCs were also found biologically active and viable as they were 
able to produce infection when inoculated in monkeys and they were also found invading 
the RBCs in /// vilro culture system. 
The purified P. knowlesi SI-RBCs were used to immunize the rabbits for raising the 
polyvalent hyperimmune serum. Two rabbits were immunized over a period of 3-4 months. 
The immune rabbit sera collected after each injection (from I to VI injections) as well as their 
YG fractions (prepared 3 times concentrated from pooled immune rabbit sera by ammonium 
sulphate precipitation) were tested for the parasite specific antibodies by employing the 
techniques of enzyme linked immunosorbent assay (ELISA), indirect haemagglutination 
assay (IHA) In both these assays, an increase in titre values with increasing number of 
immunization were observed in case of both the rabbits, however, the titre values became 
constant after IV and V injections. The ELISA was found more sensitive than IHA The 
maxiniuni values of reciprocal antibody titre were found 128000 as determined by ELISA 
and i 2800 by IHA in the immune rabbit sera collected after IV and subsequent injections in 
case of both the rabbits, however, the yG fractions of the pooled immune sera gave the 
increased values of reciprocal antibody litre of 256000 (by ELISA) and 25600 (by IHA) in 
case of both rabbits. 
The presence of protective antibodies in immune rabbit sera was demonstrated by 
examining their effect on multiplication of P. knowlesi parasites in in vitro culture system. 
The short term in vitro culture of P. knowlesi was done by candle jar method of Trager and 
Jensen (1976), separately in the presence of normal control and immune (anti-P. knowlesi 
SI-RBC) rabbit sera. Though significant rise of parasitaemia in normal rabbit sera was 
observed while no parasites were observed in presence of immune rabbit sera. Therefore, 
these results indicated the presence of protective antibodies in immune rabbit sera. 
In subsequent studies, the protein and antigenic components of P. knowlesi SI-RBC 
were analysed by employing the techniques of SDS-polyacrylamide gradient gel electrophoresis 
(SDS-PAGE) and immunoelectrophoretic techniques. The normal RBC ghost antigenic 
extract was also analysed alongwith for comparative purpose. The SDS-PAGE resolved the 
P. knowlesi SI-RBC into 30-35 major protein bands in the mol.wt. range of 15-230 KD on 
5-12% gradient of polyacrylamide. The number of protein bands present in P. knowlesi SI-
RBC were found much greater in number as well as having several additional and heavily 
stained protein bands than that in normal rhesus RBC ghost, thereby indicating certain 
qualitalivciind ciuaiitilalivedilVcrcnccs in the protein patterns of P. knowlesi SI-RIJC and 
normal RBC ghost. 
The antigenic components of P. knowlesi SI-RBC were analysed initially by employing 
the technique of Immunoelectrophoresis (lEP) using rabbit anti-P. knowlesi SI-RBC sera. 
The lEP analysis showed an increase in the number of precipitin arcs with increasing number 
of immunization. The number of precipitin arcs become constant at 12 with sera obtained 
after IV and V injections. However, only 3-4 precipitin arcs were formed with normal rhesus 
RBC ghost antigen against rabbit anti-P. knowlesi SI-RBC sera. So these results indicated 
the presence of 8-9 parasite specific antigens in P. knowlesi SI-RBC 
The antigenic components of P. knowlesi SI-RBC and normal rhesus RBC ghost were 
further analysed more clearly by employing the more sensitive technique of crossed 
imtnunoeiectrophoresis (CIE) using rabbit anti-P knowlesi SI-RBC gamma globulin 
T^63H 
fraction (yG, prepared from the pooled hyper immune rabbit seraTOut of the different 
concentrations (5%, 7.5%, 10% and 15%) ofgamma globulin fraction tried, better resolution 
of antigenic peaks was observed with 7.5% gammaglobulin concentration with P. knowlesi 
SI-RBC and 10% gamma globulin concentration with normal rhesus RBC ghost antigens. 
The CIE analysis revealed 40 antigenic peaks with P. knowlesi SI-RBC while only 6 
antigenic peaks were observed with normal rhesus RBC ghost antigens, thereby suggesting 
the presence of 34 parasite specific antigens in P. knowlesi SI-RBC. 
In order to focus attention on the common or cross reactive antigens between 
P. knowlesi and P. falciparum SI-RBCs, the triton extracts of the ^^S-methionine labelled 
SI-RBC of P. falciparum were immunoprecipitated with immune sera from patients having 
malaria {P. falciparum) infection and rabbit anti-P.knowlesi SI-RBC hyperimmune sera. The 
immune complexes formed were further analysed on SDS-P AGE followed by autoradiography. 
Instead of individual patient sera, immune serum pools (high, medium and low titred) were 
used for immunoprecipitation so as to include the widest spectrum of antibodies. The 
antibody titres of individual patient sera as well as immune serum pools were quantitated by 
IFA using P. falciparum SI-RBC as well as P. knowlesi SI-RBC antigens. The antibody 
titres were obtained more with P. falciparum SI-RBC as compared to P. knowlesi ^ X-KHC. 
The ^'S-methionine labelled proteins oi^P. falciparum after immunoprecipitation were 
analysed on SDS-P AGE, which revealed that 10-12 antigens were recognized by patient sera 
{P. falciparum) while 15-16 antigens were recognized by hyperimmune rabbit sera (anti-P. 
knowlesi SI-RBC). On comparing, 5 major antigens of 195, 120, 97, 94 and 74 KD were 
found to be common or cross reactive between these two parasites, one common antigen of 
74 KD was found most strongly recognised by all the three patients serum pools as well as 
hyperimmune rabbit serum. 
In conclusion, we have been able to purify P. knowlesi SI-RBC more than 95% (free 
from platelets and leucocytes) using glass beads and CF-11 cellulose column and subsequently 
by applying one step percoll gradient centrifugation. Immune rabbit sera raised against 
P. knowlesi SI-RBC showed high titres of parasite specific antibodies, as detected by 
(ELISA) and (IHA), thus showing the immunogenic nature of P. knowlesi SI-RBC. These 
hyper ininume rabbit anti-P. knowlesi SI-RBC sera were found to contain protective 
antibodies, as they inhibited the multiplication of P. knowlesi parasites in in-vitro culture. 
Thse SDS PAGE analysis of P. knowlesi Sl-RBC revealed the presence of 30-35 major 
protien bands in the molecular weight range of 15-230 KD. The immunoelectrophoretic 
analysis revealed the presence of 34 parasite specific antigens in P. knowlesi SI-RBC. The 
immunoprecipitation and SDS-PAGE analysis of ^'S- methionine labelled antigens of P. 
falciparum SI-RBC with malaria {P. falciparum) patient sera and hyper immune rabbit sera 
(anti-/*. knowlesi SI-RBC) pools revealed the presence of 5 common or cross reactive 
antigens of mol.wts. 195, 120, 97,94 and 74 KD between these two parasites, of these, the 
74KD antigen was found to be a major common antigen. 
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PREFACE 
Among the parasitic diseases caused by protozoa, malaria remains one of the major 
world health problems and the greatest killer of mankind. Despite all attempts of eradication 
based on vector control and chemotherapy, malaria not only continue to flourish but has 
reemerged in the areas from where once it had vanished. This is mainly due to the 
development of drug resistance of the parasite and the insecticide resistance of the mosquitoes 
and it has become obvious that neither the insecticides nor the antimalarial drugs alone are 
sufficient to control the disease. This has put impetus on finding the immunological solution 
to the disease i. e. the development of eftective malaria vaccine to supplement the existing and 
the future malaria control strategies. As the chloroquine and the multiple drug resistance 
strains of malarial parasites, particularly the Plasmoiiium falciparum (the most dreaded 
species of human malaria), are increasingly spreading in most of the tropical countries of the 
world, consequently the research activities towards immunoprophylactic measures of 
malaria have stimulated over the last decade. The development of malaria vaccine as well 
as better immunodiagnostic methods have remained the two major research priorities among 
the objectives set up by world health organisation. Therefore research in this direction will 
be of special relevance particularly for the tropical and subtropical regions of the world and 
certainly for India. 
The asexual blood stages of malarial parasites remain the main focus of immunological 
research as the morbidity and mortality due to malaria is mainly caused by these stages. The 
work reported in this thesis is directed towards the immunochemical studies on asexual blood 
stages of primate malaria parasites and deals with immunogenicity and evaluation of 
protective potential of schizont infected erythrocytes of P. knowlesi as well as identification 
of common or cross-reactive antigens between P. knowlesi and P. falciparum. These studies 
have provided useful information about the protein and antigenic make-up of P. knowlesi 
schizont infected erythrocytes and common or cross reactive antigens between schizont 
infected erythrocytes of/^ . knowlesi and P. falciparum. The information obtained from the 
present study may be regarded as baseline and may further be explored to isolate and purify 
the target antigens of P. knowlesi schizont infected erythrocytes and testing their potential 
of protective immunity in monkey model and efficacy in immunodiagnosis of human malaria. 
CHAPTER I 
INTRODUCTION 
flND 
REVIEW OF LITERfrrURE 
INTRODUCTION 
Malaria is a mosquito transmitted blood infection caused by a protozoan parasite of the 
genus Plasmodium. Since the discoveries of its causative agent, the malaria parasite, in the 
blood of a soldier by Laveran in 1880, its vector the female Anopheles mosquito by Ross in 
1897 and by Grassi in 1898 and with the better recognition of the values of Cinchona bark 
and quinine for the treatment of the disease by Pellitier and Caventou in 1820, much has been 
knwon about the life cycle of the parasite, bionomics of its vector, better understanding of 
the clinical aspects of the disease, its treatment and control strategies during the course of 
present century (Wernsdorfer and McGregor, 1988, Haworth, 1991). 
Despite the intensive investigations and major eradication programmes of WHO 
(Najera, 1989) malaria still remains one of the major world health problems, particularly in 
the tropical and subtropical countries, causing profound morbidity and mortality and its a 
great challenge to the scientists all over the world (Cook, 1989,Miller, 1992). According to 
the latest WHO report, more than 2000 million people i.e. approximately half of the world 
population in some 100 tropical and subtropical countries of the world are exposed to malaria 
of these 500 million live in tropical Africa, the highest endemic area in South of Sahara. 
According to the statistics of the United Nation's population division in 1990, malaria is the 
only disease today apart from AIDS that shows a significant rising tendency. Every year 110 
million clinical cases of malaria occur throughout the world, of which 80-90% are Africans. 
1-2 million people mostly children under 5 years of age die of malaria each year, again the 
maximum mortality occurs in tropical Africa. Apart from Africa 95% of 5.2 million cases are 
reported from other 25 tropical and subtropical countries of which mostly from India (39%), 
Brazil (11%) and rest from other countries like, in descending order, from Afghanistan, 
China, Burma, Sri Lanka, Thailand, Vietnam etc. (Liisberg, 1991, WHO, 1991, World 
Malaria Situation, 1992). As far as India is concerned, according to the WHO estimation in 
1990, out of the total Indian population, more than 95% are at risk due to malaria, a total of 
1777253 clinical cases of malaria were reported in India with a wide variation observed from 
states to states (Dutta and Bhalwar, 1991, Kondrashin, 1992). In some countries the gravity 
of malaria problem is becoming so much staggering that not only the health of the population 
is threatened but also the social and economical progress of the communities (Shepard, 1991). 
Malaria is thus one of the most serious and wide spread tropical diseases in the world today 
and a great threat to mankind. 
The malaria parasite is a haematozoan, i.e. the protozoan that lives in the blood and it 
is the small Anopheles mosquito which transmits the parasite by bitting, at random first a 
malaria patient and then a healthy person. Four species oiPlasmodium infecting mankind are 
Plasmodium falciparum, P. vivax, P. ovale and P. malariae of which P. falciparum is the 
most dreaded species of human plasmodia. Apart from human, so many other species of the 
Plasmodium have been identified infecting monkeys {P. brasiliamwi, P. coatneyi, P. 
cynomolgi, P.Jieldi, P. fragile, P. gonderi, P. inui, P. knowlesi, P. simium etc.), rodents {P. 
atheruri, P. berghei, P. chabaudi, P. vinckei, P. yoelii) and avians {P. cathemerium, P. 
gallinaceum, P. lophurae, P. relictum). 
Fig. 1 is showing the diagrammatic representation of the life cycle of a primate (human) 
malaria parasite. Malaria parasite undergoes a complex muUistage developmental cycle 
which alternates between a vertebrate iiost (man) and an invertebrate vector host (the female 
Anopheles mosquito). The life cycle begins when the sporozoites (the infective stage) from 
the mosquito's salivary gland are injected into the blood stream during the bite of an infected 
female Anopheles mosquito. With in an hour the sporozoites disappear from the blood 
circulation and especifically attach and invade the liver parenchymal cells. Within the liver 
cells the sporozoites mature and by asexual nuclear division produce multinucleate schizonts 
(Exoerythrocytic schizogony). At this hepatic or exoerythrocytic stage, the infection is 
asymptomatic and occur over a period ranging from days to months (average 2 to 4 weeks) 
depending on the species of Plasmodium. The multinucleate schizonts alongwith the infected 
liver cells, eventually burst releasing thousands of individual merozoites (upto 30000 per 
sporozoite depending on the species of Plasmodium). These merozoites enter into blood 
stream and are able to specifically attach and invade the erythrocytes and this initiates the 
erythrocytic phase of the life cycle. Within the erythrocytes, the merozoites subsequently 
develop and differentiate into rings, trophozoites and finally by asexual nuclear division get 
converted into multinucleate (8 to 24 daughter nuclei depending on species of Plasmodium) 
schizonts (erythrocytic schizogony). The parasitic cytoplasm also devides and new merozoite 
membrane then forms at the segmenter stage. Rupture of the segmenter infected erythrocytes 
releases another generation of extracellular merozoites that rapidly reinvade new erythrocytes 
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and thereby perpetuating the erythrocytic cycle of the parasite growth and so the blood 
parasitaemia rises. The duration of erythrocytic cycle depends on the species of the 
Plasmodium and is usually 24,48, 72 hrs. This erythrocytic phase of the parasite is directly 
responsible for morbidity, its clinical symptoms and mortality due to malaria. During this 
erythrocytic phase of the parasite, a portion of the blood stage merozoites after invading the 
RBCs, due to some unknwon factors get differentiated into male and female gametocytes i.e. 
the sexual stages of the parasite. The gametocyte infected erythrocytes do not rupture and 
when these are taken by the mosquito during the blood feeding, unlike uninfected erythrocytes 
and other asexual stages infected erythrocytes, they are not digested in the mosquito gut 
rather they undero gametogenesis producing male (micro) and female (macro) gametes. In 
the midgut of the mosquito, the male microgamete undergoes exflagellation producing 6-8 
microgaiuctcs. The microgamcles fertilize the large female gametes and the resultant zygotes 
elongate and rapidly differentiate into motile ookinetes. The ookinetes pierce the gut wall and 
eventually come to rest (extracellularly) between the basement cell membrane and the basal 
laminae of the midgut wall of the mosquito and round up forming the oocysts. The oocysts 
grow and usually within 7 to 15 days (mainly depends on the environmental conditions, 
particularly those of temperature and humidity), by asexual nuclear division (sporogony) 
produce several thousands sporozoites. The number of sporozoites produced within each 
oocyst depends on the species o^ Plasmodium (Rosenberg and Rungsiwongse, 1991). A 
single mosquito may carry several hundred oocysts on its midgut wall. The sporozoites are 
released from the oocyst and via the haemocoel finally lodge into the lumen of the salivary 
gland of the mosquito where they remain viable for an indefinite period until injected into 
another vertebrate host during the frequent blood meals. According to the latest view of the 
exoerytiirocytic schizogony, in some species of Plasmodia (/*. vivax, P. ovale, P. cynomolgi), 
a portion of the sporozoites after entering the liver parenchymal cells get differentiated into 
a dormant hypnozoite stage which remain viable for a longer period and eventually grow into 
schizont and are responsible for relapses (Cogswell, 1992). 
The morbidity, its pathology, clinical symptoms and mortality due to malaria is mainly 
caused by the asexual blood stages of the parasite. The clinical symptoms are characterized 
by paroxyms of periodic high fever with feeling of chills and vigour accompanied by headache, 
muscular pain, gastrointestinal upsets which then followed by profound sweating and patient 
then return to normal. The fever is associated with the bursting of schizont infected 
erythrocytes and the severity of the disease in usually proportional to the number of 
parasitized red cells. The intense destruction of the red cells may lead to other pathological 
symptoms and may cause anaemia, anoxia, haemoglobinuriae, hypoglycaemia, jaundice and 
neuropsychiatric symptoms. Other pathological symptoms include enlargment of spleen and 
liver. In case of severe P. falciparum malaria, the microvessels of the heart, lungs, kidneys, 
small intestine, liver, brain and eye may get blocked due to sequesteration of parasitized 
erythrocytes and thus preventing the normal flow of the blood and may cause haemorrhage 
and anaemia. Sequestered cells that clog the brain capallaries may reduce blood flow 
sufficiently and it may cause confusion, lethargy and unarousable coma and lead to cerebral 
malaria. The infection by P. falciparum is called falciparum malaria or malignant tertian 
malaria. P. vivax is the cause of vivax malaria and is called tertian fever or benign tertian 
malaria. The malaria caused by P. ovale is called ovale malaria which has close similarities 
to vivax malaria. The infection off. malariae (malariae malaria) results in the quatran malaria 
fever. Species responsible for the highest mortality rate especially among children is P. 
falciparum. 
The biological and morphological similarities between human and nonhuman primate 
malarias make the later good animal model of human malarias providing suitable laboratory 
host available. Much of our knowledge of human malarias have come from the studies on 
animal malarias in laboratory animals. P. knowlesi (24 hr blood cycle), P. coatnyei, P. fragile 
(48 hr blood cycle) are extensively used as a model for P. falciparum (48 hr blood cycle) type 
malaria. P. cynomolgi, P. gonderi (48 hr blood cycle) are excellent model for the study of 
P. vivax (48 hr blood cycle) type malaria. P.fieldi, P. simium (48 hr blood cycle) used as a 
model for P. ovate (48 hr blood cycle). P. inui, P. hrasilianmn (72 hr blood cycle) used as 
a biologic model for P. malariae (72 hr blood cycle). In all these cases rhesus monkeys 
{Macaca mulatla) and in some cases {P.fieldi, P. simium, P. brasilianum), Aolus or Saimiri 
monkeys are used as laboratory host. 
In 1956, prompted with the advent of the residual insecticide dichlorodiphenyl-
trichloroethane (DDT) and antimalarial drug chloroquine, WHO introduced the multibillion 
dollar Global malaria eradication programme based on vector control and chemotherapy 
(Najera, 1989), but the initial overwhelming success of effective control were turned up in 
a great setback due to the wide spread resurgence of malaria by the mid 1970s'and this was 
attributed to the development of drug resistance \n Plasmodium and insecticide resistance in 
the mosquitoes (Davidson, 1982, Werndorfer, 1991). The chloroquine and multiple drug 
resistant strains oiP. falciparum, the most malignant species of human malaria, are spreading 
in most of the tropical countries (DasKhatri, 1991, Rastogi, 1991, Louis et al., 1992, 
Wongsrichanalai, 1992) and now P. vivax is also gaining resistance to the drug (Collignon, 
1992, Murphy efal., 1993). This grim situation led the scientists and research organisations, 
such as WHO, to the revival of their approaches in malaria research not only for finding the 
better chemotherapeutic measures, but also towards finding an immunological solution to the 
disease i.e. the possibilities of producing an effective malarial vaccine as well as better 
immunodiagnostic test (WHO, 1988a,b, 1993, Howard, 1989, Marshall, 1990, Cherfas, 
1990a, Dhar, 1993). 
During malaria infection, the parasite remain susceptible to both antibody mediated as 
well as cell mediated immune defence mechanism of the host. In the recent years, there have 
been continuous efforts for developing subunit humoral response inducing malaria vaccine 
as well as malaria vaccine strategy based on T-cell and the induction of cell mediated 
immunity. In fig, 1 the number I to VII refer to the stages at which the parasite destructive 
host immune responses are believed to act and form the conceptual basis for development 
of diverse malaria vaccine strategies. 
The blood stages of malaria parasite are promising target not only for developing the 
new antimalarial drugs but also for the development of antimalarial vaccines and 
immunodiagnostic tests, because these stages are directly responsible for the morbidity, its 
clinical symptoms, pathology and mortality due to malaria. Accordingly a survey of literature 
was done on immunochemical aspects of malaria with special reference to the studies related 
to the immunodiagnosis and vaccine development against asexual erythrocytic stages of 
malaria parasites. 
REVIEW OF LITERATURE 
ISOLATION AND PURIFICATION OF BLOOD STAGES 
OF MALARL\ PARASITES 
For conducting the studies on immunochemical, biochemical, molecular and other 
aspects of malaria, the first and most important thing is to get the malaria parasites in the most 
purified form at a desired particular stage. The source for getting the asexual blood stages 
of Plasmodium may be the blood obtained either from the malaria patients, from infected 
experimental animal hosts or from the /// vitro culture of the parasites. The presence of various 
unwanted blood components such as platelets and leucocytes and erythrocyte membrane 
components may interfere the study and ultimately lead to the misinterpretation of the data 
(Howard et al., 1978). It has also been reported that the quantity of leucocytes in the blood 
circulation generally increases above the normal value during the malaria infection (Homewood 
and Neame, 1976). The complex life cycle of the parasite and its intimate association with the host 
tissues make the isolation of the intraerythrocytic parasite in an intact and purified form, a technically 
difficult task. Several mechanical, chemical and immunological methods have been used to isolate 
the malaria parasites and their constituents (Hamburgher and Kreier, 1980). 
In the first step of centrifugation and washing of infected blood, the plasma and buffy 
coat are removed and along with a population of number of platelets and leucocytes are also 
reduced (Zuckernian el al., 1967a, Beutler, 1971) but some parasitized erythrocytes which 
lie just below the buffy coat may also be loosing while removing the buffy coat (Brown et al., 
1968a, McAlister and Gordon, 1976). The further removal of the platelets was achieved by 
passing the blood through the column of glass beads (O'Brien and Heywood, 1967, Shiebel 
and Miller, 1969, Goldman el al., 1992). Addition of adenosine diphosphate in the blood 
causes clumping of the platelets and will facilitate their removal by column (McAlister and 
Gordon, 1976, Scheibel and Miller, 1969). Various methods and techniques have been 
employed for the further removal of the leucocytes from the infected blood such as by passing 
through a column of filter paper or cellulose powder (Shiebel and Miller, 1969, Cook et al., 
1969, Baggaley and Atkinson, 1972), by applying sedimentation velocity technique using 
dextron (Zuckernian el al., 1967a), by gradient centrifijgation using sucrose (Williamson and 
Cover, 1966), Ficoll hypaque solution (Wallach and Conley, 1977), by centrifugal elutriation 
technique (McEven et a/., 1971, Russman et al, 1982). Brown et al. (1966) eliminated the 
leucocytes by millipore filtration after releasing the parasite fi-om the infected cells using 5 
HM pore size. Among the various methods employed for the separation of leucocytes, the 
separation on Whatman CF-11 cellulose column has been found most suitable because of its 
simplicity and efficiency (Richards and Williams, 1973, Homewood and Naeme, 1976, 
Howard et al, 1978, Waki and Suzuki, 1986, Goldman et al., 1992). The column of 
sulphoethyl cellulose was also used for the removal of leucocytes (Howard et al., 1978). The 
cellulose column over a layer of glass beads facilitate the combined removal of platelets and 
leucocytes (Scheibel and Miller, 1969, McAlister and Gordon, 1976). 
Most of the techniques used for concentrating the parasitized erythrocytes (PRBC) 
from the infected blood are based on the diflerences in the densities of the PRBC and normal 
RBC(NRBC) (Williamson and Cover, 1966, Miller and Chein, 1971,Heidrich, 1988). In one 
of the earliest study, Eaton (1938) allowed the schizont infected rhesus blood to settled down 
slowly and collected the increased concentration of schizont infected erythrocyte just below 
the buffy coat. Subsequently density gradient centrifligation techniques were also employed 
by different workers for the separation of parasitized erythrocytes using various gradient 
materials such as human albumin (Ferrebee and Geimen, 1946), bovine albumin (Rowley et 
al., 1967, Eisen, 1977, Siddiqui et al, 1978a), sucrose (Williamson and Cover, 1966), 
phthalate (Miller and Chien, 1971), Strachtan II (McAlister and Gorden, 1976), physiogel 
(Trager and Jensen, 1976, Reese el al., 1979), plasmagel (Pasvol et al., 1978), gelatin 
(Jensen, 1978), Metrizamide, a trisodium benzamide derivatives of glucose (Engui and 
Allisen, 1979), Ficoll (Eling, 1977, Mrema et al., 1979) and percoll (Saul et al., 1982, 
Rivadeneira et al., 1983, Andrysiak et al., 1986, Waki and Suzuki, 1986, Ihalamulla and 
Mendis, 1987, Wunderlich e/a/., 1987, Haider e/a/., 1988, Handunnetti e/a/., 1992). 
The intraerythrocytic plasmodia from the parasitized host RBCs can be released by 
applying various physical and chemical procedures. Some of the physical procedures 
employed include the hypotonic lysis of the infected erythrocytes (Stein and Desowitz, 1964, 
Chavin, 1966), by French pressure cell lysis technique (Cooke/a/., 1969, D'Antonio, 1972), 
nitrogen cavitation technique (Wallach and Conley, 1977, Nillni et al., 1985) or by gentle 
sonication of the parasitized erythrocytes (Kreier et al. ,1976) or by mechanical shearing such 
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as by forced extmsion through a syringe fitted with a 27 gauge needle (Chow and Kreier, 
1972) or through a filter membrane of 35 ^M pore size (McAlister and Gordon, 1977). The 
chemical procedures have also been employed by different workers for releasing the 
Plasmodia from the infected erythrocytes such as by Ammonium chloride treatment (Martin 
etal., 1971, Prior e^  a/., 1973), by saponin lysis (Zuckermane/a/., 1967a). Subsequently the 
technique of saponin lysis was used efficiently by number of workers with slight modification 
in the amount of saponin, incubation time and temperature (Jerusalem and Elign, 1969, 
WanDyke el al., 1977, Kan and Siddiqui, 1981,BeaumeIlee/a/., 1987,Kirandee/a/., 1991). 
The mature stages of the intraerythrocytic piasmodia (Trophozoite or Schizont) may also be 
released by sorbitol lysis (Hoppe ef«/,, 1992, Handunnetti etal., 1992) but the ring infected 
and uninfected erythrocytes are not lysed by sorbitol (Lambros and Vanderberg, 1979), so 
they can be removed by filtration through 80 ^M filter after agglutination with either anti-
erythrocytic monoclonal antibodies or wheat germ agglutinin. Plasmodia may also be 
released by immunolysis i.e. by incubating with specific anti-host erythrocytic immune serum 
and compliment with gentle agitating to enhance the lysis and followed by centriftigation to 
isolate the free parasites (Trager el al., 1972, 1990), by lectin agglutination and seiving 
procedure (Nillni et al., 1981, Heidrich et al., 1982). The contamination of erythrocytes and 
their ghosts as well as the parasites still surrounded by these membranes may be eliminated 
from the freed parasites by applying different methods such as by differential centrifugation 
(Trager et al., 1990), by density gradient centrifugation using bovine serum albumin (Eisen, 
1977),sucrose(Siddiquit'/a/., 1978c),picollorpercoll(Nillni^/A/., 1981,1985, Wunderlich 
et al., 1987), and free flow electrophoresis (Heidrich et al., 1982) or by immunoaffinity 
chromatography (Hoppe et al., 1992). 
The immunochemical studies are conducted with the soluble extracted materials of the 
isolated parasites. For solubilization of parasite preparation, the nonionic detergents such as 
Berot EMU-043 or Triton-X-100 was found most suitable as it causes minimum denaturation 
of proteins during solubilization (Bjerrum and Lundahl, 1975, Deans et al., 1978, Kaushal 
etal., 1983, Gonzalez-ceron and Rodriguez, 1991). 
For getting the desired synchronised stage of development, certain procedures are 
required. The species such as Plasmodium lophtirae, P. chabaiidi, P. hwwlesi cause highly 
synchronous infections, facilitating the isolation of defined stages of these species relatively 
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easier by judicious choice of the time of blood collection (Brown et al., 1968a, Trager et al., 
1972). In case of rodent malaria parasite P. berghei, not naturally synchronised or loose 
synchrony in culture, in such cases the gradient centriftigation may be applied to get the 
desired stage of parasites (Shungu and Arnold, 1971, McAlister and Gorden, 1977). The 
synchronised stage of P. falciparum from culture may be obtained by treating the parasitized 
erythrocyte with 5% sorbitol for 2-5 min at 3TC, this destroyed the mature form of the 
parasite and only the ring stages survived which kept for further cultivation (Lambrose and 
Vanderber, 1979). a-difluoromethylornithine (DFMO) was also used to synchronize the 
trophozoite stage of the P. falciparum (Hoppe et al., 1991, 1992). 
IMMUNIZATION AGAINST ASEXUAL BLOOD STAGES 
OF MALARIA PARASITES 
The induction of protective immunity against erythrocytic stages of plasmodia derived 
from avian, rodent, simian and human malarias has been shown in appropriate experimental 
animals by immunizing with extracellular merozoite as well as with parasitized erythrocytes, 
either irradiated, heat inactivated, attenuated, killed or fractionated (Siddiqui, 1980, Deans 
and Cohen, 1983). 
In some of the earliest attempts of immunization with the avian species of plasmodia, 
the protection of canaries immunized against heat treated or formalin killed erythrocytic 
stages of/^ . cafhemurium (Gingrich, 1941) and of ducks immunized against killed erythrocytic 
stages of/*, lophurae {iacohs, 1943) have been demonstrated. Subsequently immunization 
of ducks with P. lophurae (Freunds etal., 1945a, Coffins 1951) and with P. cafhemurium 
(Thomas ef al., 1947) each incorporated with Freund's complete adjuvant (FCA) has shown 
and confirmed the effectiveness of the use of adjuvant (FCA) in immunization against 
Plasmodium. Kilejian (1978) for the first time employed purified protein for immunization 
against malaria. He immunized ducklings with a purified histidine rich protein (HRP) isolated 
from P. lophurae infected erythrocytes and protective immunity was shown to induced even 
without FCA. 
In case of rodent species of plasmodia, the effective immunization against asexual 
blood stages of P. berghei was attempted using irradiated infected blood (Wellde and Sadun, 
1967), erythrocyte free parasite (Jerusalem and Eling, 1969, D'Antonio etal., 1970) as well 
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as cell free extract and soluble homogenate (Desowitz, 1967, Zuckerman etal., 1967b, Saul 
and Kreier, 1977, Grathaus and Kreier, 1980). Active immunization of mice against saponin 
lysed formalin fixed P. yoelii parasitized cells mixed with Bardetella pertussis organisms 
(Playfair et a/., 1977) and Triton extracted erythrocytic stages of P. yoelii mixed with saponin 
(Playfair and Desouza, 1986) has been reported. Kumar et al. (1990) have reported the high 
level of protection in mice immunized with killed P. vinckei antigen with attenuated 
Typheminium. 
Among the simian plasmodia, in some of the earliest attempt of immunization against 
the blood stages of malaria parasite, although the induction of malaria antibodies in rhesus 
monkeys {Macaca mulatto) against the P. hiowlesi was demonstrated but the immunity was 
not protective (Eaton and Coggeshall, 1939, Short and Menon, 1940, Ray el at., 1941). 
Subsequently the protective immunity against P. knowlesi was demonstrated for the first time 
by immunizing monkeys subcutaneously with formalin treated schziont infected erythrocyte 
of P. knowlesi emulsified in paraffin oil containing killed tubercle bacilli i.e. the freund's 
complete adjuvant (Freund' s e/ a/. 194 5b, 1948) and subsequently by other workers (Targett 
and Fulton, 1965, Brown etal., 1970a) and it was also reported that the better immunity was 
aflbrded by intramuscular rather than subcutaneous route of immunization (Targett and 
Fulton, 1965). Subsequently the induction of protective immunity in rhesus monkey was 
demonstrated by immunizing against the partially purified fraction i.e. PPF (D'Antonio et al., 
1971) and various nonviable sucrose density gradient fractions (Simpson et al., 1974). 
Plasmodia! lyophilized antigen has also been used successfijlly for immunization (Schenkel 
et al., 1975, Cabrerra et al., 1976). In some studies, the blood stage merozoite was found 
most potent immunogen with 90-100% survival rate in rhesus monkeys against normally 
lethal challenge (Mitchell et a/., 1977a, Richards et al., 1977). However, the superiority of 
merozoite antigen could not be established in a comparative evaluation of the efficacy of three 
nonviable blood stages' antigens (merozoite, schizont, a schizont's FPC fraction i.e. a 
schizont's fraction obtained by French press cell disruption technique) of P. hiowlesi 
(Rieckmann et al., 1978, 1979). Khanna et a/. (1991) effectively immunized the rhesus 
monkeys against erythrocytic stage of P. hiowlesi and high titres of antimalarial antibodies 
were recorded. 
Immunization attempts were also made with the aim to define specific protective 
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antigens having potential value for vaccination. A 74 KD glycoprotein isolated from P. 
hiowlesi schizont infected rhesus erythrocytes was shown to induce protective immunity 
against potentially lethal infection of P. knowlesi (Schimidt-UUrich et al, 1986b). In other 
studies, a 140 KD (Miller e/a/., 1984, Klotzetal., 1987) and a66 KD (Deans etal., 1988) 
antigens of P. him'lesi were shown to induce protective immunity in rhesus monkeys. 
In some of the earliest attempts of immunization with the human malaria parasite the 
killed P. vivax blood stage antigen was used to vaccinate human volunteers but without any 
success (Heidelberger et al., 1946). Immunization of owl monkeys with irradiated P. 
faciparum infected erythrocytes however could induce only partial protection (Sadun elal, 
1969, Wellde et al., 1979). Siddiqui (1977) for the first time reported the successful 
immunization of owl monkeys against P. faldpanim blood stage (60-70% merozoites) 
antigen emulsified in FCA and demonstrated the 100% protection against strain specific 
challenge. The work of Siddiqui (1977) has also been independently confirmed by Mitchell 
et al. (1977b). Subsequently Siddiqui et al. (1978b) have also demonstrated protection 
against heterologous strain of/*, falciparum. 
During the recent years immunization attempts have been done with specific blood 
stageantigensofhuman malaria (Miller e/a/., 1986, Moreno and Patarroyo, 1989). Various 
purified recombinant and synthetic blood stage antigens belonging to merozoite surface 
(Patarroyo eM/., 1988, Huie/a/., 1991, Saule/a/., 1992, Amador e/A/., 1992a). infected 
erythrocyte surface antigens such as Pf 155/RESA i.e. ring infected erythrocyte surface 
antigen (Collins et al., 1991, Wahlin, 1990), SERA i.e. serine repeat antigens (Barr et al, 
\99\,\me\berg etal., 1991), HRPA i.e. histidine rich protein antigens (Knapped a/., 1992), 
glycophorin binding antigens (Aronson et al., 1991), rhoptries antigens (Perrin e/ o/., 1985), 
were tried for vaccination and various degrees of protection were observed using either the 
conventional FCA or several other adjuvants. Attempts has also been done to immunize 
the .40///.V monkeys passively with human antibodies against Pf 155/RESA antigens 
(BerzinstVc//., 1991). 
The importance of adjuvant in inducing protective immunity against Plasmodium was 
reported for the first time by Freund's et al. (1945a,b). He employed paraffin oil containing 
killed tubercle bacilli, latter known as Freund's Complete Adjuvant (FCA), for immunization 
against malaria. Subsequently its efficacy was established by other workers (Targett and 
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Fulton, 1965, Brown et at., 1970a). Apart from FCA so many other adjuvant materials have 
alsobeentriedby many workers such as: Freund's incomplete adjuvant (Browne/a/., 1968b, 
Butcher ei oL, 1978), adjuvant 65-4 (Schenkel ei al., 1975, Butcher et ai, 1978), saponin 
(Desowitz, 1975, Saul and Krier, 1977, Mitchell etal, 1979, Playfair and Desouza, 1986, 
Deans etal., 1988), hexylamine, Lavanisole (Desowtiz, 1975), Polyinosinic polyuridlic acid 
(poly A:U): (Brown and Tanaka, 1975, Desowitz, 1975), Polyinosinic-polycytidyiic acid 
(PolyI;C): (Desowitz, 1975), Liposome (Siddiquie/o/., 1978c), Synthetic adjuvant CP-20/ 
961 (Siddiqui et al 1981), Muramyl dipeptide (MDP) or its derivatives (Siddiqui et al. 
1978c,d, Mitchell e/a/., 1979, KhuUar and Sehgal, 1990,Khannae/a/., 1991, Collins ef a/., 
1991, Hui et al, 1991), Muramyl tripeptide (Barr et al., 1991), Baccilus calmette gnerin 
(BCG) (D'Antonio, 1974, Butcher et al, 1978), Bordetella per tusks (Desowitz, 1975, 
Playfair et al., 1977, Mitchell et al., 1979), Mycobacterium hutyrium (Mitchell et ai, 1979), 
Diphtheria toxoid (Jones et al, 1990, Collins, 1991, Saul et al, 1992), Salmonella 
typhemurium (Kumar, 1990), Trehalose dimycolate (TDM), sulpholipid (SL), Liposome 
containing Ag.'phospho-mannoinositides(PIM)':(Khullarand Sehgal, 1990),Polyalphaolifine 
(Knapp et al, 1992), Aluminium hydroxide (Butcher et al, 1978, Patarroyo et al, 1988, 
Aronsone/a/., 1991). 
Out of the so many adjuvants tried as reviewed above, no other adjuvant could be 
strongly found more potent and better substitute for FCA. However, in immunization with 
P. berghei antigen in rats using Saponin and FCA as adjuvants, it has been shown that saponin 
was belter than FCA (Saul and Kreier, 1977). Siddiqui etal (1978d) reported the successful 
replacement of FCA by stearoyl-MDP for immunization against malaria. In other comparative 
studies, the adjuvant formulations based on synthetic B-30-MDP (a lipophilic muramyl 
dipeptide derivative), LA-15-pH (a synthetic equivalent of monophosphoryl lipid A) and 
alum was found as effective as FCA in inducing antibody response against gp 195 protein but 
there were distint differences in the recognition of B cell epitopes by different adjuvants and 
it was also demonstrated that the MHC control of antibody specificity can be related to 
adjuvant used for immunization and thus suggested that the influence of adjuvants should be 
a major consideration in studies on immunogenic recgonition as well as the design of modern 
subunit vaccines (Hui et al, 1991, Hui and Chang, 1992, Millet et al, 1992), The major 
problem of adjuvant research has been to dissociate the immune response from inflammatory 
15 
side effects. FC A, the widely used potent adjuvant in experimental animals are so fraught with 
side effects that it was not licenced even for vaterinary use (Jones et al., 1989). At present 
the only adjuvant licensed for human use are mineral gels such as aluminium hydroxide which 
has been included in malaria recombinant and peptide material vaccine tested in man 
(Herrinton et al., 1987, Patarroyo ei al., 1988, 1992). 
IMMUNOASSAYS FOR MEASURING ANTIBODY AND 
DETECTING CIRCULATING ANTIGEN 
Several immunoassays viz. Enzyme linked immunosorbent assay, Indirect 
haemagglutination assays, Immunofluorescence assay have been widely used for detecting 
the antimalarial antibodies as well as the circulating antigens in the host serum. 
ENZYME LINKED IMMUNOSORBENT ASSAY 
The enzymes conjugated with antigens and antibodies have been used initially by 
several workers for localization of antigens and antibodies in tissue section (Avrameas, 1970) 
as well as for quantitative determination of antigens and antibodies in immunoelectrophoresis 
and gel diffusion (Avrameas, 1969, Stanislawski, 1970). Subsequently, the competitive 
enzyme-linked immunosorbent assay (ELIS A) for the quantitation of antigens or antibodies 
using enzymes conjugated with antibodies or with antigens fixed on a solid phase, was 
independently developed by two groups of workers, one in Sweeden using alkaline 
phosphatase enzyme, reported in a series of three papers (Engvall and Perimann, 1971,1972, 
Engvall e( a/., 1971) and other in Holland using horse radish peroxidase enzyme (Vanweemen 
and Schurs, 1971). Voller ei al. (1974, 1975) for the first time introduced this technique of 
ELISA in the field of malaria for detecting the antimalarial antibodies during P. vivax and P. 
falciparum infection using crude antigenic preparation ^xom P. falciparum schizont infected 
erythrocytes derived from Aotus monkey (Voller et al., 1974) and from P. knowlesi schizont 
infected erythrocytes derived from rhesus monkey (Voller et al. 1975). Subsequently this 
technique of ELISA has been extensively employed in the field of malaria immunology by 
various groups of workers. 
A variety of solid phases were employed in ELISA as a carrier surface for coating 
antigens, such as agarose beads (Streefkerk and Decider, 1975), desposable polystyrene 
tubes (Engvall and PeHman, 1972, Voller et al., 1975) or more suitable and generally 
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employed disposable polystyrene microtitration plate (VoUere/a/., 1974, 1977, Spencer e/ 
al., 1979a,b, Mahajan et al., 1981, Dutta e( al, 1984, Srivastava et al., 1985, Lee and 
Lambros, 1988). Nitro cellulose membrane has also been employed as carrier surface for 
coating the antigen in ELIS A (Petros et al., 1989). Among the variety of enzymes available, 
the commonly used enzyme marker in ELISA for labelling the antiglobulin conjugate are 
alkaline-phosphatase(Vollere/a/., 1974,1975,1976,1980,Mackeye/a/., 1982,Knobloch 
and Hermentis, 1987) and horse radish peroxidase (Spencer e/a/., 1979a,b, Mahajan etal., 
1981,Tharavanije/CT/., 1982, Ray er a/., 1983,Demertsera/., 1987). A number of enzyme 
substrates (chromogens) have been used in ELISA, such as P-nitrophenyl phosphate (Voller 
etal., 1974, 1975, 1980), aminosalicyclic acid (Voller e/a/., 1976), ortho-phenyldiamine 
(Spencer etal., 1979a,b, 1981, Mahajan e/a/., 1981,Duttae^a/., 1984), 4 chloro-L-naphthol 
(Londner et al., 1987) and 3-3', 5-5'-tetramethylbenzidine (Lee et al., 1990). 
ELISA has been successfully employed for detecting the antibodies against human 
malaria using crude antigenic preparation both from human plasmodia such as P. falciparum, 
derived from y4o/7/.9 monkey or from mv/Vro culture (Voller e/a/, 1974,1980, Spencer etal., 
1979a,b, Mahajan e/a/., 1981, Ray e/a/., 1983,Deloronera/., 1987, Lee and Lambros, 1988, 
Biswas and Sharma, 1991, Archibald etal., 1990, Kumar etal., 1992), P. vivax (Perez and 
dela Rosa, 1990, Gonzalezceron and Rodriguez, 1991) as well as heterologous antigen from 
simian malaria (Voller e/Of/., 1975, Mahajan eM/., 1981,Tandone/a/., 1982, Dutta e/a/., 
1984). Mitra et a/. (1991) employed ELISA using schizont enriched P. knowlesi antigen for 
the quantitation of antimalarial antibodies in cerebrospinal fluid from the cases of cerebral 
malaria. Khanna et al. (1991) employed ELISA using blood stage whole antigen of P. 
hiowlesi for the quantitation of Ab titres in the sera of rhesus monkeys immunized against 
the same antigen. Antigen isolated from the supernatant of the in vitro culture (Ray et al., 
1987) as well as lyophilized antigen harvested from in vitro culture (Sato et al., 1990) have 
also been employed successfully in ELIS A for detecting antimalarial antibodies). The specific 
peptides have also been employed as antigen in ELISA for detecting antimalarial antibodies 
(Esposito £?/«/., 1990, Deloron and Cot, 1990,Chumpitazie/a/., 1991,Collinse/fl/., 1991, 
Biswas and Sharma, 1991, Srivastava e/o/., 1991). 
A new technique of DOT-ELISA based on the same principle of ELISA for the rapid 
detection of malarial antibodies and which could be able to detect the malaria antibodies upto 
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a dilution of 1/64000 in pateint sera has been reported (Londner et ai, 1987). Some others 
more sensitive, simple, rapid and easily visible ELISA systems in which reaction can be read 
with nacked eye without using ELISA reader, have been reported for the detection of 
antimalarial antibodies specially convenient in the field study, such as one, using urease as an 
enzyme marker and urea as a substrate, named as' 'ELIS A-U'' (Lee and Lambros, 1988) and 
other one using avidin biotin peroxidase complex enzyme i.e. "ABC-ELISA" (Sato et ai, 
1990). Baruch e( a/. (1991) employed a sensitive fluorescence cell ELISA method for the 
detection of antimalarial antibody. Dziegiel etal. (1992) described a novel 'U' chain capture 
ELISA for the detection of IgM antibodies against P. falciparum antigen. Boraker et al 
(1992) have reported the use of Acoustic probe-based ELISA. ELISA system has also been 
employed for the diagnosis of malaria based on detecting circulating antigen using refined 
antibody (IgG), such as against P. vivax (Wang etal., 1987), P. falciparum (Bualombai et 
al., 1990). Khullar and Sehgal (1989) employed ELISA for the detection of circulating 
antigens in the sera of mice infected with P. berghei. Avidor et al (1992) used the cross 
reacting monoclonal antibodies against P. berghei for the identification of P. falciparum 
antigen using a sensitive ELISA system. An improved and more sensitive sandwitch ELISA 
technique for the detection of blood stage malarial antigen in human plasma by employing 
monoclonal antibodies against P. falciparum (Dubary et al. 1990) and P. vivax (Gao et al., 
1991) has also been reported. 
In a comparative evaluation ELISA is found more superior and sensitive than other 
immunological techniques such as IHA and IFA (Mahajan et al., 1981, Khanna, 1991). 
INDIRECT HAEMAGGLUTINATION ASSAY 
The idea that the various substances can be absorbed on the surface of red blood 
corpuscles without significant damage to the cells, and these can then be agglutinated by 
serum antibodies against the attached group (Pressman et al., 1942, Middlebrook and Dubos, 
1948) led the evolution of haemagglutination test to be a valuable technique for detecting 
circulating antibodies developed against variety of antigens, both polysaccharide and protein 
in nature (Boyden, 1951, Ingraham, 1952, Wright and Feinberg, 1952, Stavitsky and 
Arquilla, 1955, 1958, Lunde and Jacobs, 1959). Various coupling agents were used to bind 
antigens to red blood cells for passive haemagglutination test, such as dizotised arsalinic acid 
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and bisdiazotized benzidine (BOB) (Pressman e/a/., 1942), tannic acid (Boyden, 1951), 1,3 
difluoro-4,6-dinitrobenzene (Ling 1961), tolylene-2-diisocyanate (Gyenes and Sehan, 1964) 
and corboiimide (Johnson et al., 1966). The BDB and tannic acid techniques are well 
established methods for detecting small quantities of antibodies and antigens (Stavitsky, 
1964). These methods in general, however, have the disadvantage of being somewhat 
complicated and time consuming. A more easier and rapid chromic chloride (Crcl^) method 
for binding of antigens to red cells is reported (Gold and Fudenberg, 1967). The problem of 
poor stability and variable sensitivity among different lots of sensitized erythrocytes, 
prompted the use of some fixative agent to stablize the red blood cells for their use in 
haemagglutination test. Out of the various stabilizing agent employed, such as formaldehyde 
(Daniel et al., 1963), pyruvic aldehyde (Hirata and Brandriss, 1968), the glutaraldehyde 
fixation of erythroytes was found superior and the cells were found stable for at least six 
months (Bing ei al., 1967. Hirata and Brandriss (1968) employed the stabilized sheep, 
chicken and rabbit erythrocytes and reported the optimum conditions such as pH, antigen 
concentration and the duration of contact with antigen for the better coating of variety of 
polysaccharide and protein antigen with RBCs. 
The technique of haemagglutination has been employed earlier in the serology of 
parasitic infections, such as schitosomiasis and trichinosis (Kagan, 1955, Kagan and bargai, 
1956) and toxoplasmosis (Lunde and Jacobs, 1959). Desowitz and Stain (1962) for the first 
time introduced this technique in the field of malaria for the quantitation of antibody titres 
of rat antisera against P. herghei antigen using tanned sheep erythrocytes and subsequently 
in human,Stein and Desowitz (1964) employed formolized tanned sheep erythrocytes 
sensitized with P. vivax for measuring the malaria antibody in patient sera. Later on, the 
simplicity and rapidity of this test, called as indirect haemagglutination assay (IHA), led the 
several groups of workers to employ this technique for immunodiagnosis and epidemiological 
surveillance of human malaria using homologous antigens from P. falciparum (Meuwissen, 
1974, Meuwissene/fl/., 1974, Mathews e/a/., 1975, Gupta e/a/., 1979, Ray e^  a/., 1981, 
DnhQy etai, 1989, Marwahe/«/., 1989),/^. v/vax (Mathews e/a/., 1973, 1975) as well as 
heterologous antigens from simian malaria parasites such as P. brasiliamim (Mathews 
and Dilworth, 1976), P. knowlesi (Kagan, 1972, Lobel etal, 1973, Collins et al., 1975, 
Bagchic'/a/., l978,Mahajane/a/., 198I,Chandananit'/a/., 1981,Agarwale/a/., 1982,Nath 
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etal., 1984, Saxenae/a/., 1988), P. cy/jowo/g/(Mamtani e/a/., 1979, Nathe/a/., 1984). 
P. cynomolgi antigen was found more superior than P. knowlesi antigen for the detection of 
P. vivax infection (Nath et ai, 1984). More sensitivity and specificity of IHA was observed 
by using the homologous antigens as compared to the heterologous antigens (Lobel et ai, 
1973;Meuwissene/a/., 1974, Mathews e/a/., 1975, Comille-Broggrere/a/., 1978, Gupta 
et a/., 1979, Ray et ai, 1981, Chandanani et al, 1981). Antigen harvested from in vitro 
culture (Gupta el al., 1981, Ray el al., 1981) as well as lyophilized fixed erythrocytes 
(Meuwissen, 1974) were also employed successfully in IHA. Meuwissen et al. (1972) using 
various simian malaria antigens and human malaria patient sera, reported the various technical 
aspects of the haemagglutination assay for malaria with particular attention of the influence 
of heterophile antibodies (the antibodies reacting with antigenic determinants of noninfected 
heterologous erythrocytes) and in some infections the production of agglutinins against host 
erythrocytes components, so he advocated the absorption of sera with tanned sheep cells 
sensitized with noninfected host red blood cell antigen as a control on the IHA titre for specific 
agglutins. 
In a comparative evaluation with other immunological assays, it was reported that in 
the younger age group (under 10 years), as well as during the initial infection, the 
immunofluorescence assay (IFA) detect the antibodies slightly more efficiently than the IHA, 
but in the adults and after several months of infection, the IHA tended to detect antimalarial 
antibodies more efficiently than IFA. The IHA also detected significantly higher malaria 
antibody litres in patients who had previously been infected with malaria (Wilson etal., 1971, 
Meuwissen, 1974, Meuwissen e/a/., 1974, Collins e/a/., 1975, Chandanani e/a/., 1981). 
Some other workers reported IHA in general somewhat less sensitive than ELISA and IFA 
(Mahajant'/a/., 1982, Agarwal t'/a/., 1981, Khannae/a/., 1991). 
IMMUNOFLUORESCENCE ASSAY 
Coons et al. (1942) for the first time reported that antibody could be labelled with 
fluorescent dye in such a manner that it retained its capacity to react specifically with the 
antigen. Since then, this finding has been applied for the immunospecific staining of a variety 
of microorganisms including various protozoans, such as Entamoeba histolytica. Entamoeba 
coli (Goldman, 1954), Toxoplasmai^ondi (Goldman, 1957), Trypnosoma cvuzi (Fife and 
Mushel, 1959). The credit for the application of this technique in malariology goes to Brooke 
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et al (1959), who reported the staining of P. berghei with fluorescein labelled globulin 
fraction of anti-P. berghei hyperimmune rat serum. Subsequently using this method, Tobie 
and Coatney (1961) were able to stain P. vivax and P. cynomolgi and Ingram et or/. (1961) 
could differentiate P. cynomolgi basitianelli from P. gallinaceum. Later on several groups 
of workers extensively employed this technique of immunofluorescence assay (IF A) for the 
detection of antibodies against various species of rodents, avians and simian malaria (VoUer, 
1962, Kreier and Ristie, 1964, Collins*?/a/., 1967, Gabriel e/a/., 1986,Nguyen-Dinn(?M/., 
1988) and for the immunodiagnosis and seroepidemiological survey of human malaria using 
homologous as well as heterologous antigen (McGregor et al., 1965, Fisher et al, 1970, 
Collins e/a/., 1975, Lobel and Kagan, 1978, Warren e/a/., 1983, Agarwal e/a/., 1983, 
Rayefa/., 1986, Benzerroughe/a/., 1986,Bjorlcmane/a/., 1990,Larie/a/., 1991, Kumar 
etal, 1992). 
The technique of IF A was found highly specific in infections with the genus Plasmodium 
and failed to reveal cross reactions with other infections such as trypanosomes, leishmaniids 
and ascariids (Kuvin et al., 1962, Voller, 1962, Ciuca et al., 1964), however this test is not 
found sufficiently specific to differentiate strains and species of Plasmodia as the cross 
reactivity between different species ofPlasmodium has been demonstrated by various groups 
of workers (Voller and Bray, 1962, Diggs and Sadun, 1965, Collins et al., 1966). The 
superiority of homologous antigen over the heterologous antigen has also been reported in 
IFA (Diggs and Sadun, 1965, Collins et al., 1966, Umgureanu et al., 1980). 
Initially thin blood smears which required high parasitaemia were employed in IFA 
(Tobie and Coatney, 1961, Voller, 1962, McGregor etal., 1965) but subsequently use of 
thick blood smears at much lower parasitaemia have been used (Sulzer et al., 1969, Voller 
and O'Neil, 1971, Thomas and Ponnampalam, 1975, Mahajan et al., 1981, Agarwal et al., 
1981). Collins and Skinner (1972) have employed hydrochloric acid (HCI) for the 
dehemoglobinization of blood smear but Voller (1975) reported the drop in IFA titres with 
the use of HCI. Modified immunofluorescence assay (MIFA), by using glutaraldehyde fixed 
and air dried monolayers of ring infected erythrocyte (RES A) of P. chabaudi (Gabriel et al., 
1986), P. fragile (Nguyen-Denh et al., 1988) and P. falciparum (Perlmann et al., 1984, 
Deloron and Cot, 1990, Ruangjirachuporn et al., 1991) have also been reported. Antigen 
harvested from /// vitro culture oH'. falciparum have also been employed in IFA (Sodeinde 
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and Williams, 1990, Kumar et ai, 1992). Rubik et al. (1989) used the lyophilized antigen 
prepared from continuous hi vitro culture. 
The comparative study of IF A with other immunological techniques such as IHA and 
ELIS A for the serodiagnosis and seroepidemiological survey of human malaria has also been 
reported (Bray and Elnahal, 1966, WHO, 1974, Collins et al, 1975, Agarwal et al, 1981, 
Mahajane/al, 1981, Srivastavag/a/., 1991, Decarvalhoera/., 1992). 
IN VITRO CULTURE OF ERYTHROCYTIC STAGES OF 
MALARIA PARASITES 
The investigations on immunological and other aspects of malaria require continuous 
supply of Plasmodium parasite in sufficient quantity. Due to less availability and difficulty in 
getting the suitable experimental hosts, the constant supply of malaria parasite remains a 
major problem among the malariologist. This led the scientists to attempt to cultivate malaria 
parasites //; vitro system. Several attempts were made to establish the short term as well as 
continuous /// vitro cultivation of malaria parasites and to develop in vitro assay systems. Bass 
and Johns (1912) for the first time reported the in vitro cuhure of human malaria parasites 
P. falciparum and P. vivax by incubating the whole difibrinated malaria patient blood 
supplemented with glucose at 37''C and observed the maturation of ring and sometimes the 
formation of new generation of invasive merozoites which rarely even leads to one or two 
additional cycles. During the subsequent years several attempts were made to see the effect 
of a variety of agents and different conditions such as temperature etc. on in vitro growth of 
the malaria parasites (Manwell and Hewitt, 1937, Hewitt, 1938). In these studies although 
the infectivity and survival of the parasite was observed for few days but no common 
agreement on conditions favourable to the /// vitro growth of the parasite could be established. 
However, Trager (1941, 1943) has reported the first in vitro culture of P. lophurae upto 16 
days and somewhat comparable results were obtained by Coulston (1941) for //; vitro culture 
of P. circumjlexum and by Hawking (1945) in the case of P. gallinaceceum. Geiman et al 
(1946) has employed two different techniques of rocker dilution and rocker perfiision for in 
vitro cultivation of P. hiowlesi and obtained about 4 fold multiplication in 24 hr. Ball et al 
(1945) and Anfinsen etal (1946) while working at Harvard on in vitro growth of P. knowlesi 
in rhesus monkey erythrocytes described a synthetic nutrient medium (later known as 
Harvard medium) for /// vitro growth of malaria parasites. Subsequently several groups of 
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workers have tried in vitro cultivation of erythrocytic stages of various species of Plasmodium 
using Harvard growth medium with different modifications and reported the effects of 
various components in the culture medium (McGhee and Trager, 1950, Geiman etal., 1966, 
Trager, 1971, Siddiqui and Schnell, 1973, Williams and Richards, 1973,Diggse^a/., 1975, 
S'lddiqui etal., 1975,Trig, 1975). In most ofthese studies with the erythrocytic stages ofboth 
human and other nonhuman species of malaria parasites only one or at the most a few cycles 
of development in //; vitro culture were observed, but even these short term experiments were 
found useful in accessing chemotherapeutic, biochemical and immunological studies. 
However, Trager (1976), after screening a number of different tissue culture media using 
J\ coatneyi in rocker dilution flasks discovered that the medium RPMI-1640 (originally 
prepared by More et al. (1967) for the culture of human leucocytes) supplemented with 25 
nilVlN-2liydroxycthylpipcraziiic-N'-2-clliaiic sulfonic acid (MlilMiSbuHcr) was significantly 
superior than the Harvard medium. Finally two groups of workers namely Trager and Jensen 
(1976) and Haynes et al. (1976) independently reported the successful continuous in vitro 
cultivation of erythrocytic stages of P. falciparum. Trager and Jensen (1976) have employed 
RPMl (Rosen Park memorial Institute) -1640 medium supplemented with HEPES buffer (25 
mM) and 2% NaHCO^ with 10% human type AB serum either using a continuous flow vial 
method in an atmosphere of 7% CO ,^ 1 or 5% 0^ and 92-88% N^ or using a simple candle 
jar method producing an atmosphere of low O^  and high CO^ content incubated at 37° and 
normal change of medium daily. Haynes et al. (1976) have used the modified tissue culture 
medium-199 (with Earle's modified salts), enriched with glucose (2 mg ml'), 2 mM 
glutamine, 3x I O'M 2-mercaptoethanol, (±) a-tocopherol (emulsified) (30 \xg ml'), plus 10% 
heat inactivated foetal bovine serum and 10 mM N-Tris-(hydroxymethyl)-methyl-2-
aminoethane sulphonate (TES) buffer, using culture flask/microtitre plates in an atmosphere 
of 3% CO ,^ 6.6% Oj and balanced nitrogen at 37°. Subsequently Jensen and Trager (1977) 
have reported /// vitro cultivation of P. falciparum using petridishes held in candle jar with 
manual change of medium daily. This method known as petridish-candle jar method is the 
most widely used method for /// vitro cultivation of the blood stages of malaria parasites. Later 
on several groups of workers successfully developed in vitro cultivation of P. falciparum in 
RPMI-1640 medium, using the gas mixture or candle jar by employing the basic techniques 
of Trager and Jensen (1976) or with some modifications, such as using petridishes or culture 
23 
flasks for the large scale cultivation of the parasite (Trager and Jensen, 1980, Kaushal et ai, 
1980, Ifediba and Vanderberg, 1980, Butcher, 198 la,b, Trager, 1982,Fairlambe/a/., 1985, 
Misra et ai, 1989, Sodeinde and Williams, 1990, Trager et al, 1990, Hoppe et ai, 1991, 
1992, Read, 1992, Trager and Gill, 1992). Some of the Indian isolates oi P. falciparum have 
also been established in in vitro culture (Gajananae/a/., 1982, Guptaera/., 1983, Sivaraman 
elai, 1983, Kaushal, 1988). Chowdhuri e/a/. (1979) have reported the mixed culture of P. 
falciparum and P. malariae. 
Although Larrouy etal. (1981) have reported the culture of P. vivax for 43 days by 
using essentially the similar method of Trager and Jensen (1976) except using higher glucose 
level and change of medium thrice daily rather then once, however in several other attempts 
to adapt the P. falciparum culture system to P. vivax no significant success could be achieved 
(Siddiqui, 1979, Chowdhury^/a/., 1982, Renapurkar<?/a/., 1983, Brockelmanc/a/, 1985, 
Mons et ai, 1988). Recently Lanners (1992) reported the prolonged in vitro cultivation of 
/'. vivax using Iiagcr's continuous flow method. 
The //; vitro culture of several species of simian plasmodia such as P. hwwlesi (Butcher, 
1979, Wickhamt?/a/., 1980), P. cynomolgi {Nguyen-D'mhetai, 1981,Zhaoxie/af/., 1984), 
P. fragile (Chin etai, 1979) and rodent malaria parasites such as P. berghei (Guru and Sen, 
1980, Mons et ai, 1983) P. chabaudi (Mclean et ai, 1986) have also been established by 
employing the basic technique of Trager and Jensen (1976) or with some modifications. 
The various species o^ Plasmodium were cultured using erythrocytes obtained from 
their natural hosts, such as simian species ofPlasmoditmi have so far only been successfiilly 
cultured in erythrocytes from rhesus (Macaca mulatto) or kra (M. fascicularis) monkeys, 
while human erythrocytes were considered to be suitable for continuous culture of P. 
falciparum, however the in vitro culture of P. falcipanmt mAotus trivirgatus erythrocytes 
has also been reported (Peterson et ai, 1984). Jensen and Trager (1977) reported that 
erythrocytes from blood stored in acid citrate dextrose (ACD) or citrate-phosphate dextrose 
(CDP) until they were outdated for blood banking purposes may still be used for in vitro 
culture of J\ falciparum. Capps and Jensen (1983) reported that the erythrocytes stored for 
84 days in adenine supplemented CDP were still suitable for P. falcipanm culture. 
The problem of acquisition of sufficient quantity of human serum on regular basis and 
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moreover the possibility of its contamination of hepatitis viruses and other pathogens and 
presence of possibly inhibiting malarial antibodies and chemotherapeutic agents specially in 
malarious region, led to the attempts to replace the human serum with serum obtained from 
a variety of animals such as horse, bovine, calf, swine, lamb, sheep, rabbits etc. and successful 
/// vitro culture off. falciparum is reported (Jensen, 1979, Butcher, 1979, Ifediba and 
Vanderberg, 1980, Siddiqui 1981, Raichowdhury and Sivaraman, 1982, D'woetal., 1985, 
Grun and Weidanz, 1987). The /// vitro culture oiP. falciparum upto four weeks or longer 
has also been reported in serum free RPMI-1640 medium supplemented with adenosine, fatty 
acid-free BSA and oleic or cis-vaccenia acid (Willet and Canfield, 1984). 
Different methods were applied for the synchronization of parasites in vitro culture 
such as percoll gradient centrifugation (Ruangjirachuporn et al., 1991), by treating with D, 
L-a-difluoromethylornithine (Assaraf ^/a/., 1986) or by Sorbitol treatment (Lambros and 
Vanderberg, 1979, Read, 1992). Hoppe et al. (1991) reported a comparative study of 
different synchronization methods for //; vitro culture of malaria parasites. 
The /// vitro culture system, beside providing the basic need of obtaining malaria 
paraistes, has opened many avenues for research which would lead on the one hand to 
illuminate the basic cell biology of the parasite and their relationship to the host erythrocytes 
and on the other hand for approaching practical goal in chemotherapy and vaccine 
development. The in vitro culture system has been employed successfully by number of 
workers for studying the effect of immune sera on growth and invasion of malaria parasites (Cohen 
era/.,1969, Miller e?/a/., 1975, Perrine/a/., 1981, Campbell e/a/., 1986, Trager, 1987, Perlaza 
etal, 1990,Barre/a/., 1991).TheefFectongGandIgM(Fandeure/a/., 1984,Browne/a/., 1982a, 
1986, Berzins et al., 1986, Wahlin et al., 1990) as well as monoclonal antibodies against the target 
blood stage antigens of P. falcijxirum (Schmidt-Ullrich et al., 1986a, Epping et al., 1988, 
Ramaswamye^a/., 1990),P. hio»>lesi(Epstemetal., 1981,Millere/a/., 1984, Deametal., 1988), 
P. yoe/ii (Freeman et al, 1980) on growth and invasion of parasites have been studied using 
in vitro culture system. Recently McNally et a/. (1992) have reported a simple in vitro invasion 
assay for studying the erythrocyte invasion of rodent malaria parasites P. berghei and P. c. 
chabaudi. Trager and Gill (1992) by employing the///v//ra culture demonstrated the enhanced 
gametocyte formation in young erythrocytes of P. falciparum. 
Trager and Williams (1992) reported the extracellular (axenic) development of atleast 
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one complete erythrocytic cycle of P. falciparum in in vitro using 24 well culture plate and 
candle jar by suspending the erythrocytic merozoite in a medium of sonicated erythrocyte 
having ATP, pyruvate and mixed with matrigel to form a soft gel, which is overlaid with 
complete liquid medium-KF, a high potassium modification of RPMI-1640 medium, that is 
replaced with fresh medium at appropriate intervals of 12, 24 and 36 hr. At all these times 
and also at 45 hr rhodamine 123 was added to same culture and gels were sampled. They 
observed the viable extracellular forms showing rhodamine fluorescence: rings at 12 hr, 
trophozoite and early schizonts with pigment at 36 hr and late schizonts with developing 
merozoites at 45 hr. These merozoites were found infective to erythrocytes added to the 
culture at 45 hr. Moreover in the electron micrograph of 36 hr trophozoite, only single plasma 
membrane is observed and no parasitophorous membrane is seen. Thereby they concluded 
that for the development of merozoite through it complete asexual cycle, the complex process 
of its entry into erythrocyte, the intactness of the host erythrocyte and the parasitophorous 
membrane are not essential. 
ISOLATION AND CHARACTERIZATION OF 
MALARIAL ANTIGENS 
Malaria parasites are having a complex mixture of antigenic components having both 
common or cross reactive as well as stage, species and strain specific antigens (Collins et al., 
1966, Deans t'/fl/., 1978, Kilejian, 1980, Miller < /^a/., 1980, Browne/a/., 1982b, Kaushal 
el al., (1990), Moelans and Schoenmakers, 1992). Total cell free extracts therefore need to 
be analysed into component antigens in order to focus attention on those antigens which are 
potent immunogenic and to identify and characterize any particular cross reactive or specific 
antigen. So it will provide more rational basis for developing effective malarial vaccine as well 
as specific immunodiagnostic test. Number of techniques based on immunoprecipitation and 
immunoelectrophoresis in agar gel system such as double diffusion (Oucherloney, 1958), 
immunoelectrophoresis in agar gel system (Graber and Williams, 1953), immunoprecipitafion 
of metabolically labelled antigens (Epstein et al., 1981), SDS-polyacrylamide gel 
electrophoresis (Lacmmli, 1970), autography, flurography and several other chromatographic 
techniques have also been employed in the field of malaria for the analysis, identification, 
isolation and characterization of plasmodial antigens. 
The analysis and isolation of the antigens from the parasite and from the host 
26 
erythrocyte membrane requires the solubilization of the collected parasites and separation of 
the soluble from the insoluble materials by extraction and centrifligation. Extraction buffer 
containing a cocktail of protease inhibitors (in order to protect the antigens from the attack 
of the proteases and other digesting enzymes, so as to get the isolated antigens as intact as 
possible) and a number of nonionic or ionic detergent such as Lubrol, various Tritons, 
Nonidet NP 40, Desoxycholate or Zwittergent 314 etc. were employed for solubilizing the 
parasite components (Leech el al., 1984, Howard and Barnwell, 1984). The nonionic 
detergent Triton X-100 or Berol EMU-043 has been found suitable as it causes minimal 
protein denaturation (Bjerrum and Lundall, 1975, Bjerrume/a/., 1975, Deans e/a/., 1978, 
KaushaU/a/., 1983). 
In some of the earliest attempts, the presence of both species specific and cross reactive 
antigens between the rodent malaria parasites P. vinckei and P. berghei has been reported 
by applying the technique of immunoelectrophoresis in agar gel system(Spira and Zuckerman, 
1966). Subsequently by applying the techniques of double diffusion and immunoelectrophoresis, 
the antigenic analysis of various species of plasmodia such as P. lophura (Sherman, 1964), 
P.gallinaceum(Smithetal., \969),P. berghei(Diggs, 1966,Zuckerman etal., 1969,Steitz, 
1972), P. cynomolgi (Banki and Bucci, 1964), P. knowlesi (Brown et al., 1970b), P. 
fa/cipanim (Mcgregor etal., 1966, Turner and McGregor, 1969a,b, Wilson, 1970, Wilson 
e( al., 1969, 1975a,b, 1976) were reported. Sherman (1964) has reported the antigenic 
analysis of the avian malaria parasite P. lophiirae by double diffusion and immunoelectrophoretic 
techniques and demonstrated the presence of haemoglobin as one of the major antigenic 
components as a contamination in parasite antigenic preparation. Smith etal{\ 969) identified 
a soluble antigen and its specific antibodies in the sera of chicken infected with P. gallhiaceum 
by employing the techniques of double diffusion and immunoelectrophoresis. Diggs (1966) 
studied the antigenic analysis of rodent malaria parasite P. berghei by employing the 
technique of double diffusion and immunoelectrophoresis using hyperimmune rabbit serum 
and drew attention to the presence of antibodies against antigens of host origin such as 
haemoglobin and other serum components and emphasize that their presence must be taken 
into consideration in accessing the results. In another study Zuckerman et al. (1969) by 
employing the double diffusion in agar gel system reported the kinetics of the production of 
precipitin lines in one hundred and eleven samples of the rat anti-/^ berghei sera obtained 
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during the primary infection and found the 55% precipitin positive reaction. A series of 
subsequent eight times hyperimmunization by reinoculation of viable P. berghei raises the 
percentage of positive test from 55% to 75% while the vaccination with cell free plasmodial 
product before challenge with viable parasites raises the percentage of positive test to 100%. 
The species specificity ofatleast part of the precipitins was demonstrated but no antierythrocytic 
precipitin was recognized. Steitz (1972) has employed the techniques of double diffiasion and 
immunoelectrophoresis to demonstrate the presence of soluble antigens in the sera of mice 
infected with 7^ . berghei. Browne/a/. (1970b) have employed the double diffusion technique 
for analysing the antibody response in the anti-P. kncwlesi rhesus monkey sera and reported 
the appearance upto three precipitin lines with sera having chronic infection and four strong 
precipitin lines with sera from vaccinated monkey against P. knowlesi schizont extracts, some 
lines were found strain specific while others were common to various strains off. hios\>lesi. 
McGregor et al. (1966) has also employed the technique of gel diffusion for analyzing the sera 
collected from individuals exposed to P. falciparum in Gambia. In other studies by applying 
the technique of gel diffusion two kinds of antigens: a-antigens (mol. wt. 300-900 KD) and 
P-antigens (mol. wt. 50-60 KD) in the extract of P. falciparum infected placental blood were 
reported (Turner and McGregor, 1969a,b). Wilson et al. (1969, 1973) by employing the 
technique of gel diffusion using the anti-P. falciparum sera from Gambian individuals 
detected the various P. falciparum soluble antigens in the plasma of many individuals (mostly 
children) with acute infections and other antigens from the infected blood cells and typified 
them according to their thermostability into heat labile 'L' (with subclass La', La^ Lb), heat 
resistant 'R' (with subclass, R', R )^ and heat soluble 'S ' groups of antigens. Wilson (1970) 
in a Separate study reported the considerable degree of common antigenicity among these 
'S ' , 'L' and 'R' groups o^^. falciparum antigens from the two widely separated area of 
Gambia and Nigeria in West Africa. These 'S' , 'L' and 'R' groups of antigens were also 
reported in the peripheral blood o^ Aotus monkey infected with P. falciparum and their 
antigenicity were compared with antigens obtained from the human source by employing the 
gel diffusion technique (Wilson and Volier, 1972), Subsequently the technique of gel 
diffusion has also been employed to study the frequency of the occurrence of soluble 'S ' 
antigen in the sera of individuals having P. falciparum infection following antimalarial 
treatment and during subsequent parasitic episodes in the same individuals (Wilson et al. 
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1975a,b). In another study, Wilson etal. (1976) successfully detected precipitating antibodies 
to malaria'S' antigens by gel diffusion in the sera from young Gambian children with acute 
P. falciparum malaria. 
Spira et al. (1966) have reported the application of a sensitive disc gel electrophoresis 
technique for analysing the protein constituents of different species oiPlasmodium such as 
rodents {P. berghei. P. viuckei), chicken {P. gallinaceum) and monkeys {P. knowlesi, P. 
cynomolgi-B) and found the difference in the relative positions of protein bands in the 
electrophoretic patterns of various plasmodia. Smith et al. (1969) employed the disc gel 
electrophoresis technique for the characterization of soluble antigen and its antibody in the 
sera of chicken infected with P. gallinaceum. Steitz (1975) has employed a more sensitive, 
rapid and simple technique of counter current Immunoelectrophoresis using cellulose acetate 
membrane as matrix for the detection of malarial antigen and antibodies in the sera of mice 
and rats having P. berghei or P. vinckei infections. 
One of the most sensitive technique for analysing the antigens and antibodies is the cross 
Immunoelectrophoresis (CIE). Bjerrum and BOG Hansan (1976) employed this technique 
for the characterization of the erythrocyte membrane proteins immunochemically SDS-
PAGE is the widely used technique for analysis, identification, characterization and even 
semi preparative isolation of proteins (Laemmli, 1970). Subsequently, the techniques of SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) and CIE have been successfully employed 
by several groups of workers for analysing the protein and antigenic constituents of the 
erythrocytic stages of the various species of rodent (Carlsson et al., 1984, Panton et al., 
1984a,b) and simian (Butcher et al., 1978, Deans et al, 1978, Deans and Cohen, 1979, 
Schmidt-Ullrich tV«/., 1979, Miller t'/«/., 1980, Epstein tVa/., 1981, Anders, 1985, Haider, 
1990) malaria parasites. The antigenic composition of different erythrocytic stages off*. 
hiowlesi has been analysed by employing the technique of CIE using a pool of immune rhesus 
monkey IgG and the presence of nine stage independent (shared by rings, trophozoites, 
schizonts and merozoites) and two stage specific (one specific to trophozoite and other was 
restricted to tnature schizont and merozoite) antigens out of the eleven major parasite 
antigens were identified (Deans eM/., 1978, Deans and Cohen, 1979). Schmidt-Ullrich and 
Wallach (1978) detected three P. knoule.si schizont specific antigens out of the seven parasite 
specific antigens identified in the membrane of the parasitized erythrocytes by employing the 
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techniques of CIE and CLIE using monkey anti-P. hiowlesi schizont serum. In another study 
Schmidt-Ullrich ei al. (1979) immunochemically analysed the two strains of P. knowlesi using 
IgG fractions of monkey anti-P. knowlesi schizont hyperimmune serum and sera from 
naturally immune monkeys and found that only two out of the >20 antigenic components in 
the Triton X-100 solubilized schizont infected erythrocytes of P. knowlesi were recognized 
during the course of natural infection. Panton et al. (1984a,b) have identified a strain specific 
antigen of P. yoelii (Py-1) by employing the technique of CIE. Carisson et al. (1984) analysed 
the Triton X-100 extracts of the erythrocytes infected with P. chabaudi and P. yoelii by CIE 
using rabbit antisera, about 12 immunoprecipitate were obtained with both the extracts and 
their homologous antiserum and the cross test showed that two species of Plasmodium are 
very similar antigenitically, however the CLIE with intermediate gel containing the 
heterologous antisera demonstrated the presence of atleast one antigen specific for each 
of the parasite extracts. 
The metabolic radio labelling techniques have also been employed for the identification 
and isolation studies of malaria antigens. Radiolabelled amino acids incorporated in proteins 
are traced in this technique. '"C, ^ 'S or '^'I amino acids are generally used for labelling proteins. 
'^ C glucosamine or ''*C sugars are used for labelling parasite glycoproteins whereas 
radioactive fatty acids such as palmitic acid are used to label lipids or glycolipids (Heidrich, 
1988). Radiolabelling are carried out in in vitro culture using special cultural medium having 
particular labelled constituents. For successful labelling the selection of appropriate time 
during the life cycle of the parasite is also important (Venot-Hernandez and Heidrich, 1984). 
For labelling the surface proteins of infected erythrocytes, merozoites or other cells '^'I 
labelled amino acids are mostly used. Among the various methods of labelling such as iodogen 
procedure (Markwell and Fox, 1978, Heidrich et al., 1983), iodobead procedure (Markwell, 
1982), the lactoperoxidase procedure (Phillips and Morrisen, 1971, Heidrich e/a/., 1983) is 
found most ellective. Some proteins can only be labelled with a specific amino acid and will 
not be traced when other radiolabelled amino acids are used, for example a protein or a 
histidine rich protein will be more easily found when proline or histidine label is used 
(Hadley et al., 1983). The detergent extracts from parasites containing radiolabelled antigen 
may then be immunoprecipitated by reacting with immune sera either from patients, from 
endemic area or from hyperimmune animals or with monoclonal antibodies and the immune 
30 
complex formed may further be analysed by SDS-PAGE, autoradiography and fluorography 
{Howard etal., 1983). 
Attempts were also made to fractionate plasmodial extracts in order to isolate and 
purify any individual antigen. Plasmodial extracts from human (Mahoneyer a/., 1966, Sadun 
and Gore, 1968, lurner and McGregor, 1969a), Simian (Cook el ai, 1969) and rodent 
sources (Chavin, 1966, Wellde er a/., 1969, D'Antonio ef a/., 1970) have been fractioned. 
A variety of fractionation procedures have been employed such as centrifiigation and 
extraction (MahoneyeCfl/., 1966, Cook era/., 1969), salting out (Welldee/a/., 1969), Disc 
electrophoresis (Hamburger and Zuckerman, 1976a,b) and various chromatographic 
procedures such as molecular sieving (D'Antonio etal., 1970, Turner and McGregor, 1969a, 
Wilsont'/a/, 1969, Wilson and Ling, 1979,Strychera/., 1986). Ion exchange chromatography 
(Welldet'/i//., 1969, Sadun t'/«/., 1969, McAlister, 1972, Saxena t'/a/., 1988) and affinity 
chromatography (Jungery et al., 1983, Wahlin et ai, 1990). 
THE PROSPECTS OF MALARIA VACCINE 
During the recent years attempts has been focussed to immunize against purified 
antigenic components as candidate vaccine from different stages o{Plasmodium in order to 
induce specific protective immunity (McGregor, 1988, Phillips, 1992) and efforts were done 
to develop malaria vaccine based on the humoral mediated immunity as well as the vaccine 
strategy based on T cell and the induction of cell-mediated immunity (Cattani, 1989, Good, 
1992, Good elal., 1992, Romero, 1992, Diggs, 1992, McGregor, 1993) against different 
stages of malarial parasite such as sporozoite (Chulay, 1989, Good, 1990, Hoffman 
etal., 1991, Herrington, 1991), liver stage (Mazier e/a/., 1990, Cox, 1992), merozoite 
(Sharma«?/«/., 1992, Kumar eM/., 1992a, Copper, 1993), intraerythrocytic stage (Butcher, 
1989, Moreno and Petarroyo, 1989, Weidanz et ai, 1990, Long, 1993) as well as sexual 
gamete stage (Targett, 1990, Kaslow 1990, 1993). Attempts has also been done to develop 
antitoxin vaccine i.e. the toxic substance released by the parasite when the infected RBCs 
rupture and it may be neutralize by inducing specific immunity (Playfair et ai, 1990). The 
vaccine strategy based on T cell and cell mediated immunity (Special issue, 1990, Quakyi 
et ai, 1992, Hviid et al, 1992, Waki ei ai, 1992) involves the role of macrophages, 
granulocytes (Ferrante et ai, 1990, Turrrini et ai, 1992, Schwarzer et ai, 1992), natural 
killer (NK) cells, MHC and HLA (Riley et ai, 1992, Hill et ai, 1992), C-creative protein 
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(Chagnon, 1992), and number of cytokines (Vreden etal., 1992, Toverne, 1993), such as 
gamma interferon (Maheshwari e( al., 1990), tumour necrosis factor (Clark et al., 1990, 
Clark, 1992) etc. 
Out of the different antigenic component tried only three malaria vaccine candidate 
antigens were used for the clinical trials in human volunteers. Two of them were based on 
the immunodominant epitopes of the circumsporozoite proteins, the main component of the 
surface coat of malaria sporozoite: one consisted of a 12 amino acid synthetic peptide 
(NANP)^ (Herrington et al, 1987) and other was a recombinent polypeptide containing the 
NANP repetition 32 times and linked to a 32 amino acids of the tetracycline resistance gene 
: R 32 tet 32 (Ballou et al., 1987). The third vaccine which is used in the III phase clinical 
trial is the blood stage synthetic vaccine 'SPf 66', consisted of three merozoite specific 
peptides (35 KDa, 55 KJDa and 83 KDa) hybridized into a 45 amino acids peptide, deviced 
by Columbian biochemist Dr. Mannuel Patarroyo who after a suscessftil trial in owl monkey 
Aotiis trivUgalis (Patarroyo et al., 1987) finally tried in human volunteers using aluminium 
hydroxide as adjuvant and again found a very promising result with 80% protection 
(Patarroyo et al., 1988). But in other independent trials conducted at Centre for Disease 
Control (CDC)in Atlanta, USA(Ruebush^/a/., 1990)and in Columbia(Herrerae/a/. 1992), 
the results of Patarroyo could not be reproduced. Though the Patarroyo attributed the failure 
of the other groups to the problem of the peptide-BSA conjugation process (Patarroyo, 
1990), but the Patarroyo vaccine came in skepticism and his work was criticized on several 
grounds such as, the extent of malarial endemicity in some study regions was not certain and 
his human trials were not critically controlled and contained no placebo groups, experiments 
were not randomised and double blind and the malaria infection rates among the unvaccinated 
controls were low, so the efficacy of Patarroyo's SPf 66 vaccine remained doubtful and even 
the Britain's Medical Council (MRC) refused to sanction a further randomised double blind 
protocol for trial in Gambia in the Western Africa, a highly endemic area oiP. falciparum, 
on the ground that the available technical data on Patarroyo's vaccine were not adequate to 
justify the MRC support for the experiment in humans (Cherfas, 1990b, Brown, 1991, 
1992a). Despite all these setbacks Patarroyo's group continued his field trials and finally came 
up with an improved version of SPf 66 vaccine (now consisted of three merozoite specific 
peptides (35 KDa, 55 Kda and 83 Kda), hybridized to a 45 amino acids peptide and with an 
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extra tetrapeptide sequence from a CS protein and then polymerised to form a synthetic 
vaccine) and again with a claim of 80% protection rate against P. falciparum (Salcedo eiai, 
1991, Amador, 1992b, Patarroyo, 1992). After a lot of controversies and skepticism, the 
Patrroyo's SPf 66 vaccine has now been taken seriously by World Health Organisation and 
many other human trials are in progress and their results will soonly decide the efificacy and 
future of Patarroyo's vaccine (Brown, 1992b, Marshal, 1992, Cox, 1993). 
The slow progress of malaria vaccine development may be attributed to the complex 
life cycle of the parasite, its changing morphology and the nature of its interaction with its 
host. During malarial infection the immune defence mechanisms of the host and immune 
evasion mechanisms of the malarial parasite remain interplay with each other. The parasite 
has evolved number of strategies to evade the host immune response such as antigenic 
variation, antigenic polymorphism, antigenic mimicry and direct interference with the 
generation of the host immune response (Pereira de Silva, 1990, Biggs et al., 1991, Mendis 
etal., 1991, Kumaratilake and Ferrante, 1992, Theunder, 1992, Howard, 1992). 
THE PROSPECTS OF DIAGNOSIS OF MALARIA 
Malaria is often an underdiagnosed and neglected medical emergency (Oliver et al., 
1991, Rougment e( al., 1991, Cook, 1992, Van Den Ende et al., 1992). The criteria for 
detection and diagnosis of malaria include: sensitivity, specificity, simplicity in application, 
unambiguous interpretation and rapid turn around time (Pammenter, 1988, Payne, 1988). 
Presently the differential Giemsa stained thick and thin blood smear, examined under the 
microscope remains the most reliable and definitive test for the diagnosis of malaria (Shute, 
1988, Makler and Gibbins, 1991). The fluorescent dye benzothiocarboxy purine (BCP) has 
also been employed for the microscopic detection of/*. /iz/tv/wn//;; and it was found more better 
and advantageous than the standard Giemsa stain (Makler et al., 1991, Cooke et al., 1992). 
Recently, a rapid and more sensitive acridine organe fluorescent microscopy using the 
quantitative bufly coat capillary (QBC) tube was employed for the detection of Plasmodia 
(Lev'meefa/., 1989, Rickman, 1989, Wongsrichanalai^/a/., 1991,Poggenseee/a/, 1992),but 
in the field trial it met several difliculties and also found less sensitive than the conventional thick 
and thin blood smear Giemsa staining method (White and Silamut, 1989, Baird etal., 1992). 
Recent studies on the parasite genome (Weber, 1988, Triglia etal., 1992) and progress 
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in the field of biotechnology led the production of pure malarial antigens by genetic 
manipulation (Scaife et ai, 1986, Godson, 1986) and specific monoclonal antibodies by 
hybridoma technology (Kamber et al., 1992) which may be used for the development of 
alternate diagnosis tests to microscopy based on molecular detection and immunodetection 
of malaria (WHO, 1988b, Nantulya. 1991). 
Molecular diagnosis of malaria employed the techniques of DNA hybridization, use of 
specific DNA probe and polymerase chain reaction (PCR) procedure for the detection of 
malarial parasite in the blood (Tirasaphan et al., 1991, Vanden berg et ai, 1991, Barker et 
al., 1992, Sethabulo, 1992, Wooden <?/«/., 1992, Brown era/., 1992, Wataya, 1993). RNA 
probe has also been used for detecting Plasmodium falciparum parasitaemia (Watt et 
al., 1992). 
Immunodiagnosis of malaria is based on the detection of ciculating antigen using 
refined IgG or monoclonal antibodies (Wang et ai, 1987, Khusmith et al., 1988, 
Buamlambaie/a/., 1990, Dubarrye/^/., 1990, Choudhury^'^/., 1991, Gao etal, 1991, 
Avidor et al., 1992) as well as detecting malarial antibodies in the serum using plasmodial 
antigens (Londner etal, 1987, Lee and Lambros, 1988, Fruth et al., 1989, Dubey, 1989, 
Srivastava et al., 1991, Kumar et al, 1992) by employing various immunological techniques 
such as enzyme linked immunosorbent assay, DOT-ELISA (Londner et al, 1987), 
immunofluorescence assays indirect haemagglutination assay, radioimmunoassay etc. 
Enzymes have also been exploited for the diagnosis of malaria, such as by plasma 
lactate dehydrogenase (LDH) estimafion (Klenerman e/a/., 1992), by measuring the 
activity of parasite LDH(MaklerandHinrichs, 1993) and by detecting parasite LDH using 
Plasmodium specific anti-LDH antibodies by immunodot enzyme staining test (Kaushal, 1993). 
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SCOPE AND PLAN OF WORK 
The conventional methods available for malaria control based on insecticides such as 
dichlorodiphenyl trichloroethane (DDT) to kill the vector, and anti-malarial drugs, such as 
chloroquine to treat the infected individuals are steadily declining in efficacy, mainly due to 
the development of insecticide resistance in mosquitoes and drug resistance in malaria 
parasites, specially in Plasmodium falciparum. This situation has resulted in the wide spread 
resurgence of malaria even in the areas from where once it had vanished. The chloroquine 
and multiple drug resistant strain oU\ falciparum is increasingly spreading in many areas of 
the world including India. This grim scenario led the scientists and research organisation such 
as WHO not only for finding the better chemotherapeutic agents but also twoards finding an 
immunological solution of the disease such as the development of effective malarial vaccine 
to supplement the existing and future malaria control strategies. 
The development of malarial vaccine as well as better immunodiagnostic methods are 
the two major objectives of the scientific working group (S WG) of WHO on the immunology 
of malaria (IMMAL) since it was set up in 1976. During the recent years there has been 
considerable efforts for developing effective malarial vaccine against different developmental 
stages of malarial parasites viz. sporozoite, asexual blood stages as well as gametes. 
However, the asexual blood stages remain the main focus of malarial research on vaccine 
development and immunodiagnostics as the morbidity, its clinical symptoms and mortality 
due to malaria is mainly caused by these stages. Therefore the research in this direction will 
be of special importance particularly for the tropical and subtropical regions of the world and 
certainly for India. 
The morphological and biological similarities between human and nonhuman primate 
malarias makes the later good animal model for human malarias providing suitable laboratory 
host available. So the work reported in this thesis is directed towards the immunochemical 
studies on asexual blood stages of Plasmodium knowlesi, a simian malaria parasite and P. 
falciparum (the human parasite) and deals with the following aspects: 
(1) IMMUNOGENICITY AND PROTECTIVE POTENTIAL OF PLASMODIUM 
KNOWI.ESI SCHIZONT INFECTED ERYTHROCYTES 
1 I Isolation and purification of Plasmodium knowlesi schizont infected erythrocytes 
(PK SI-RBC) 
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1.2 Immunization of rabbits against P. knowlesi Sl-RBC and quantitation of parasite 
specific antibodies in hyperimmune rabbit sera. 
1.3 In vitro evaluation of rabbit anti-P. knmvlesi SI-RBC sera for protective potential of 
antibodies. 
(2) PROTEIN AND ANTIGENIC ANALYSIS OF P. KNOWLESI/P. FALCIPARUM 
SCHIZONT INFECTED ERYTHROCYTES 
2.1 Protein pattern of P. knowelsi SI-RBC. 
2.2 Antigenic analysis of P. knmvlesi SI-RBC. 
2.3 Identification of common or cross reactive antigens of P. knowlesi and P. falciparum 
SI-RBCs. 
CHAPTER II 
NflTERI^LS ^ND METHODS 
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MATERIALS AND METHODS 
PARASITES 
Plasmodium knowlesi 
A malasiyan 'H' strain of Plasmodium hiowlesi (Chin etai, 1965) procured from Dr. 
Louis H. Miller, Malaria Section, Laboratory of parasitic Diseases, national Institute of 
Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA, was used 
in the present study. 
Plasmodium falciparum 
An Indian isolate (DCK-1) of J'/asmodiumfalciparum (Kaushal, 1988) isolated from 
the blood of a malaria patient admitted to the Cant Hospital, Lucknow, India, was maintained 
in culture and used in this study. 
EXPERIMENTAL ANIMALS 
Monkeys 
Rhesus monkeys {Macaco mulatto) of either sex weighing 3 to 6 kg were obtained from 
the Primate House of the Central Drug Research Institute (CDRI), Lucknow, India. Monkeys 
free from other haemoprotozoan infections and tuberculine infection were quarantined for 
one month before using them for malaria infection. 
Rabbits 
Albino rabbits of either sex, weighing 1.5 to 2.0 kg were obtained from the inbred 
coloney, maintained in the animal house of the Central Drug Research Institute (CDRI), 
Lucknow, India. 
All the animals used in the study were kept in separate cages, housed in air conditioned 
rooms and fed on standard pellet diet, supplemented with green vegetables, seasonal fruits 
and socked grams. 
CHEMICALS USED 
Acrylamide, agarose, ammonium persulfate, bisacrylamide, bovine serum albumin, 
bromoohenol blue. Coomassie brilliant blue rR-250V ethvlenediamine tRtra aretir. arid 
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(EDTA), goat anti-human IgG -FITC conjugate, glutaraldehyde, HEPES, 0-phenanthroline, 
0-phenylene diamine, p-chloromercuric benzoate (PCMB), percoll, phenylmethylsulfonyl 
fluoride (PMSF), protein-A-peroxidase conjugate, Protein-A-Sepharose CL-4B gel, p-
tosyl-L-lycine chloromethyi ketone (TLCK), saponin, sorbitol, Triton X-100, and L-1-
tosylamide-2-phenylethyl chloromethyi ketone (TPCK) were procured from Sigma Chemical 
Company, St. Louis, MO, USA. CF-11 cellulose powder was procured from Whatman, 
USA. Freund's complete and incomplete adjuvants were obtained from Difco Detroit, MI, 
USA. The powdered RPMI-1640 medium was obtained from Gibco Laboratories, NY, USA. 
All other chemicals used were of analytical grade. Triple distilled water was used in all the 
experiments. 
MAINTENANCE OF PLASMODIUMKNOWLESI 
INI ECnON 
Plasmodium hiowlesi infection was maintained in normal rhesus monkeys (Macaco 
mulatla) of either sex, weighing 3-6 kg, by giving intravenous standard inoculum of 1x10^ 
infected erythrocytes drawn from an infected donar monkey. The parasitaemia was monitored 
daily by examining the Giemsa stained thin blood smears of the infected monkeys under the 
light microscope using oil immersion lens (lOOx). Approximately two thousands cells were 
counted before recording any final observation. 
ISOLATION AND PURIFICATION 0¥ PLASMODIUM 
KNOfVLESI SCHIZOJST INFECTED ERYTHROCYTES 
(Sl-RBCs) AND SAPONIN LYSED SCHIZONTS (SLS) 
(i) Separation of platelets and leucocytes 
30-40 ml P. knowlesi infected monkey blood at 20-30% parasitaemia (mainly 
schizonts) was drawn in 8-10 ml prechilled acid citrate dextrose (ACD) and after that the 
infected monkeys were cured by administering chloroquine hydrochloride intravenously at 
a dose of 20 mg/kg body weight at the first day followed by 10 mg/kg body weight on the 
two successive days. The infected monkey blood was washed twice with phosphate buffered 
saline (PBS, pH 7.2) by centriftjgation at 800xg for 10 min in order to remove plasma and 
buffy coat. The washed blood cells were suspended to their original volume in PBS (7.2) to 
which 1 ng/ml of adenosine diphosphate was added and mixed for 2-3 min. The platelets and 
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leucocytes were removed by passing the washed blood through the column of glass beads and 
CF-11 cellulose powder as described by Scheibel and Miller (1969). Briefly for removing the 
platelets, the glass beads (0.012 to 0.11 mm, scientific products) were washed by immersion 
in concentrated sulfuric acid, rinsed extensively with water until free of acid and then dried 
at 85°C. The dried beads (1.5 gm per ml blood) were packed with light tamping into a glass 
column (approximately 19 mm internal diameter) supported by a plug of glass wool. The 
washed parasitized blood was passed through this column (the flow was maintained at 
approximately 19 drops per min by positive air pressure) and the platelet free eluate was 
collected. For removing the leucocytes, the platelet free eluate collected from the column of 
glass beads was immediately passed through another column of dry cellulose (CF-11) powder 
(in a ratio of 1 gm of cellulose powder per 10 ml ofblood. All these operations were performed 
at 4-8"C. The eluated blood obtained from the cellulose column (now free from platelets and 
leucocytes) was washed with PBS (pH 7.2) by centrifligation at SOOxg for 10 min and was 
finally made to approximately 40% haematocrit in PBS (pH 7.2) and it was then used for 
fiirther isolation of schizont infected RBCs and erythrocyte free parasites. 
(ii) Purification of P. kiiowlesi Sl-RBCs 
The purification of/', hwwlesi schizont infected erythrocytes (SI-RBCs) was achieved 
by employing one step percoll gradient centrifijgation. Different gradients of percoll (40-
70%) were tried for finding the optimum gradient of percoll. Isotonic percoll was prepared 
by adding nine volumes of percoll to one volume of lOXPBS (pH 7.4) and the desired 
concentrations of percoll (40-70%) were made by diluting the isotonic percoll preparation 
with PBS. Now the 15.0 ml of the 40% haematocrit of the washed blood (free from platelets 
and leucocytes) was layered over the 15 ml of the different percoll gradients in 50 ml 
centriftjge tubes. The loaded tubes were then centrifuged at SOOxg for 20 min at room 
temperature (25-40"C). A dark brown band at the interface containing schizont infected RBC 
was collected and washed twice with PBS (pH 7.2) in order to remove the percoll. Giemsa 
stained thin blood smears of these preparations were examined under the light microscope. 
The optimum concentration of percoll i.e. on which the best separation of SI-RBCs is 
achieved was used in fiirther experiments. The purified SI-RBCs were stored at -70''C 
until used 
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(iii) Releasing the parasites from thc^  host erythrocytes 
For the preparation of erythrocyte free P. hiowlesi schizonts, the purified schizont 
infected suspension of monkey blood at 40% haematocrit (as obtained above) was lysed with 
saponin following the procedure of Zuckerman et al. (1967a) with some modifications. 
Briefly, the 40% suspension of the blood was treated with twice the volume of 0.15% saponin 
by keeping for 1 hr on ice with occasional stirring. The lysate was then centrifliged in cold 
(4''C) at 1 OOOOxg for 10 min. The pellet containing the released parasites i.e. the P. knowlesi 
saponin lysed schizonts (SLS) was washed with PBS (pH 7.2) in order to remove the saponin 
and haemoglobin. Giemsa stained thin blood smears of these preparation were made and 
examined under the light microscope. The P. knowlesi SLS preparation was stored at -70°C 
until used. 
RAISING HYPERIMMUNE SERUM 
The polyvalent hyperimmune serum against P. knowlesi SI-RBC and normal rhesus 
RBC ghost were raised in albino rabbits by immunizing intramuscularly with 1x10' SI-RBCs/ 
0.5 mg normal rhesus RBC ghosts protein emulsified in Freund's adjuvant separately over 
a period of 3-4 months. For preparing one injection, the required quantity of antigen was 
diluted to 0.5 ml with PBS (pH 7.2) and then mix with equal volume of Freund's adjuvant 
and emulsion was prepared by thorough mixing and each rabbit was immunized with 1 ml of 
antigenic emulsion. One month after the first injection with Freund's complete adjuvant 
(FCA), three subsequent injections were given with Freund's incomplete adjuvant (FIA) at 
15 days intervals and the rabbits were bled one week after each injection from the marginal 
ear vein. After that the rabbits were immunized and bled at an interval of 15 days. The blood 
was allowed to clot and left overnight at 4''C. The serum was separated by centrifuging at 
800xg for 10 min and kept separately in small aliquots at -20°C until used. 
PREPARATION OF GAMMA GLOBULIN FRACTION 
The hyperimmune sera (rabbit anti-P. knowlesi SI-RBC/normal RBC ghost) collected 
after 4th injection were pooled separately and use to prepare the gamma globulin fraction (yG) 
by ammonium sulphate precipitation. Ammonium sulphate was added to a concentration of 
45% to the pooled serum with continuous gentle stirring for 4 hr in cold (4-8''C). The 
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precipitate obtained by centrifugation at lOOOOxg for 30 itiin, was dissolved in minimum 
volume of normal saline (0.15 MNaCl) and analysed first against normal saline for 1 hr and 
finally against borate buffered saline (BBS) of pH 8.4 with several changes till the last dilysate 
gives -ve test for BaSo4 with cone. BaCl^  soln. After complete dialysis, the gamma globulin 
fractions was collected and kept at -20°C until used. 
ENZYME LINKED IMMUNOSORBENT ASSAY 
The enzyme linked immunosorbent assay (ELISA) was performed following the 
method of Voller et al. (1974) with some modifications. The ELISA was standardised for 
determining the optimum concentrations of antigen, anti- IgG conjugate, substrate (0-
phenylene diamine, OPD) and hydrogen peroxide (Hp^)- Briefly, the 96 well ELISA plate 
was coated with antigen by dispending different concentrations of P. ktiowlesi SLS antigen 
(0.0625 - 4 ng/100 nl/well) diluted in 0.05 M PBS (pH 7.4) and the plate was incubated for 
18-20 hr at 37"C. The plate was then washed three times with PBS -Tween (0.05 M PBS, 
pH 7.4, containing 0.05% Tween) for removing the unbound antigen. The blocking of the 
uncoated sides of the wells was done by dispensing 200 ^ 1 of 1 % powdered dairy milk protein 
(in PBS, pH 7.4) in each well and the plate was incubated at 37°C for 2 hr. After washing the 
plate again three times with PBS-Tween, the different dilutions of the test sera (prepared in 
1 % milk proteins) were dispensed (100 i^l) in the wells and the plate was again incubated at 
37"C for 2 hr. The plate was washed again three times with PBS-Tween and then 100 ^1 of 
protein-A peroxidase (1:500 to 1:4000 in 1% BSA) was added to each well and the plate was 
incubated again at 3 7"C for one and half hr. After subsequent three washing with pBS-Tween, 
100 |al of freshly prepared substrate 0-phenylene diamine (OPD) solution (0.25 mg-2.0 mg/ 
ml dissolved in citrate phosphate buffer , pH 8.0) containing 0.5-4.0 \i\lvn\ of hydrogen 
peroxide (H^O )^ was added to each well. The plate was incubated in dark for 5-10 min for 
developing colour and then the reaction was stopped by adding 50 ^1 of 5N H^SO^ in each 
well and the result was recorded as extinction (O.D. at 492 nm) in ELISA reader. 
INDIRECT HAEMAGGLUTINATION ASSAY 
The indirect haemagglutination assay (IHA) was performed according to the method 
as described in WHO bulletin (1974) using glutaraldehyde fixed tanned sheep erythrocytes 
(SRBCs) 
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(i) Preparation of sheep erythrocytes (SRBCs) 
10 ml fresh sheep blood from a normal heahhy sheep was collected in 12 ml of sterile 
Alsever's solution (pH 6.1) and was stored at 4°C for 24 hr. The plasma and buflfy coat were 
removed and the packed SRBCs were washed three times with prechilled PBS (pH 7.2) by 
centrifuging at 1 lOOxg for 10 min in cold (4°C). 
(ii) Stabilization of SRBCs 
The stabilized SRBCs were prepared by fixation with glutaraldehyde following the 
method of Bing etal. (1967). Briefly, a 3% SRBCs suspension was made in 1% ice chilled 
glutaraldehyde (pH 8.2) and was fixed by incubating in ice cold water for 30 min with 
intermittent shaking. The fixed SRBCs were then washed five times with chilled PB S (pH 7.2) 
and five times with chilled distilled water by centrifligation at llOOxg for 10 min in a 
refrigerated centrifuge. Finally a 30% suspension of these fixed SRBCs was made in distilled 
water and stored in aliquots of 1 ml at 4"C. This can be successfully stored for a period of 
6 months. 
(iii) Tanning of fixed SRBCs 
One ml suspension of 30% stabilized SRBCs was mixed with 9 ml of freshly prepared 
chilled tannic acid solution (1:40000 w/v). This suspension was incubated in ice cold water 
for half an hr with intermittent shaking in 2-3 min intervals and then washed three times with 
PBS (pH 7.2) by centrifiiging at llOOxg for 10 min at room temperature. Finally a 3% 
suspension of this tanned SRBCs was made in 0.15 M PBS (pH 5.5). 
(iv) Sensitization of SRBCs with antigen 
Firstly, the optimum sensitizing concentration of antigen {P. knowlesi SLS) was 
determined. Different concentrations of antigen (0.0625-2 fig/25 ml of 1.5% cell suspension) 
were added in separate tubes containing 1 ml of 3% tanned SRBCs. These cells were then 
incubated at 37"C in water bath for 30 min with intermittent shaking at every five min. These 
cellswerethencentrifugedat 1 lOOxg for 5 min at room temperature and subsequently washed 
twice with prechilled 1 % nomial rabbit serum (NRS) in PBS (pH 7.2). Finally these sensitized 
cells were suspended separately in 2 ml of 1 % NRS which gives the final cell suspension of 1.5%. 
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(v) The test system 
The indirect haemagglutination assay was performed in 96 well' V shaped microtitre 
plate, the two fold dilutions (1:100 to 1.102400) of normal control (reference -ve) and 
immune serum (reference +ve) were made in 1% NRS (made in PBS, pH 7.2) and added 100 
Hl/well of each in separate rows of the microtitre plate. Then 25^1 of the final 1.5% suspension 
of sensitized SRBCs was added in each well and the mixture was shaken gently for 2 min and 
kept for 2-3 hr at room temperature and haemagglutination pattern was recorded. A 
haemagglutination pattern is considered to be negative when the button formation (due to 
the sedimentation of the SRBCs) appears in the wells. The end point of the test was read as 
the last but one dilution of the serum showing button formation. The optimum sensitizing 
concentration of antigen is that minimum concentration which gives highest titre with immune 
serum (Reference +ve). The titration of other immune sera may be measured alongwith 
reference +ve and reference -ve controls by employing the SRBCs sensitized with optimum 
concentration of antigen. 
INDIRECT IMMUNOFLUORESCENCE ASSAY 
The indirect immunofluorescence assay (IFA) was done as described by Epstein etal. 
(1981), For preparaing the IFA slides, the schizont infected blood ^wmP. falciparum in vitro 
culture/R ktiowlesi infected monkey at 5-6% parasitaemia was taken in acid citrate dextrose 
(ACD), and washed three times with phosphate buffered saline (PBS, pH 7.2) by centrifliging 
at llOOxgfor 10 min in cold (4"C). After final washing a 3% suspension of the parasitized 
RBCs was made in PBS (pH 7.2) and 10% normal human/monkey serum was added. This 
suspension was applied as spots on clean grease free microscopic slide (one drop per spot 
and 8 spots per slide). The slides were air dried at room temperature wrapped individually 
in tissue paper and stored at -70"C in polythene bags until used. 
For performing the test first the slides were fixed by keeping in chilled acetone in a 
couplingjar for 30 min at -20"C and then washed with PBS (pH 7.2) for 10 min. The different 
dilutions of the test sera along with reference -ve and reference +ve control sera were applied 
(15 ^l) gently on the coated antigenic spots and the slides were incubated for 45 min in a moist 
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chamber at room temperature. After three washing with PBS (pH 7.2) by dipping in coupling 
jar for 10-10 min each time, the fluorescenated conjugate (goat anti-human IgG-FITC 
conjugate) diluted (1:40) in PBS (pH 7.2) was applied on the antigenic spots and slides were 
further incubated for 30 min in the moist chamber at room temperature. The slides were 
further washed three times with PBS (pH 7.2) and then mounted with 90% glycerol made 
in PBS (pH 7.2) and examined under the Leitz orthoplan fluorescent microscope. The end 
point of IFA titre value represents that dilution of the test serum which gives visually 
detectable fluorescence. 
m VITRO CULTURE OF P. KNOWLESI/R FALCIPARUM 
PARASITES 
The /// vitro culture of P. ktiowlesi/P. falciparum was done following the candle jar 
method of Trager and Jensen (1976). 
(i) Preparation of RPMI-1640 medium 
The medium used for culture was prepared by dissolving one packet (10.4 gm) of 
RPMI-1640 (GIBCO, USA) and 5.94 gm of HEPES in 960 ml of triple distilled water. This 
solution is filtered through 0.22 \xxn millipore filter for sterilization and dispensed 100 ml each 
into screw capped bottles. The sterility of the medium was tested by incubating an aliquot 
of sterilized medium in 5.0 ml of thioglycolate at 37''C for 7 days. A 5% solution of sodium 
bicorbonate (NaHCO^) was prepared in triple distilled water and sterilized separately by 
millipore Alteration. 4.2 ml of this 5% NaHCOj solution and 0.25 ml of gentamycin (10 mg/ 
ml) was added to 100 ml of RPMI-1640 medium just before use. 
(ii) Establishing the in vitro culture 
For establishing the///V/7/0 culture ofP. hiowlesi, the blood from a P. yb/oWe^;'infected 
monkey was drawn asceptically at a parasitaemia of 3-4% and diluted with normal monkey 
blood to a parasitaemia of 0.5%. The blood was washed three times with RPMI-1640 medium 
by centrilugation at 800xg for 10 min and finally the RBC pellet was suspended in the RPMI-
1640 medium to get an 8% suspension of erythrocytes. Two milliliters of this 8% suspension 
of infected erythrocytes were taken in 10 ml glass vials (20 mm x 50 mm) and 200 pi of heat 
inactivated normal rabbit/monkey serum was added to it and the vials were kept in candle jar 
at 37"C. The medium was changed daily with fresh medium containing 10% normal rabbit/ 
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monkey seaim and the cells were suspended by gentle swirling and replaced in candle jar at 37°. 
The parasitaemia was monitored daily by counting the parasites in Giemsa stained thin blood 
smears. These cultures were maintained for 4-5 days (upto the parasitaemia of 6-8%) and then the 
subcultures were done by diluting the culture with fresh normal rfiesus monkey erythrocytes. 
(iii) Testing the effect of immune rabbit sera on the 
multiplication of the R knowlesi parasites. 
For testing the effect of immune sera on the multiplication of the P. knowlesi parasite, 
the in vitro culture was started at 0.5% parasitaemia (mainly ring stage) and run for 48 hr in 
presence of immune rabbit serum by changing the medium at every 24 hr following the method 
described above. Control cultures were also run simultaneously using normal rabbit sera. The 
parasitaemia was monitored and compared at every 24 hr from each culture group by 
examining the Giemsa stained thin blood smears under the light microscope. 
IN VITRO CULTURE OF P. FALCIPARUM 
An Indian isolate of Plasmodium falciparum, DCK-1 (Kaushal, 1988) isolated from 
the blood of a pateint admitted to the Cant Hospital, Lucknow was maintained in vitro culture 
using normal human erythrocytes by the candle jar method of Trager and Jensen (1976) as 
described earlier in the case off. knowlesi parasites. The culture was maintained for 4-5 days 
and after that subculture was done by dilution with normal human erythrocytes. P. falciparum 
SI-RBCs from this culture was used to prepare the IFA slides as well as for the preparation 
of antigen. 
PREPARATION OF NORMAL RHESUS RED BLOOD 
CELL GHOSTS 
The normal rhesus red blood cell (RBC) ghsots were prepared following the method 
of Fairbank ct at. (1971) which is based on the principle of hypotonic lysis (Dodge et al., 
1963). Briefly the normal rhesus monkey blood (25 ml) was drawn in acid citrate dextrose 
(ACD). The plasma and buffy coat were removed and the cells were washed three times with 
PBS (pH 7.2) by centrifuging at SOOxg for 10 min and finally suspended in an equal volume 
of PBS (pH 7.2). The hemolysis of this RBC suspension was performed in 5 mM phosphate 
buffer of pH 8.0 (3 ml aliquots of RBC suspension per 42 ml of phosphate buffer) by mixing 
the contents with gentle swirling for 10 min in cold (4°C) and then centrifiiged at 32000xg 
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for 40 min in a refrigerated centrifuge. The pellet containing the RBC ghosts was hemolysed 
again and washed three to four times with phosphate buffer (5 mM, pH 8.0) by centrifugation 
at 32000xg for 40 min. The creamy pellet i.e. the RBC ghost preparation was isolated and 
kept prozen at -70"C until used. All the process were performed in cold at 4". 
PATIENT SERA 
Immune sera from patients having malaria (P. falciparum) infection were collected at 
State Ayurvedic Medical College, Lucknow and tested by IFA for the presence of malaria 
specific antibodies. Three serum pools (high, medium and low titred) were prepared by 
mixing 5 sera, each having approximately same titre of antibodies against P. falciparum SI-
RBC in IFA. 
METABOLIC LABELLING OF SCIIIZONT INFECTED 
ERYTHROCYTES WITH ^^S-METHIONINE 
The metabolic labelling of schizont infected erythrocytes (SI-RBC) oiP. falciparum 
(from //; vitro culture) was done by in vitro incubation with "S methionine in 25 cm^ culture 
flasks as described by Epstein e/a/, (1981). //; vitro cultures o^P. falciparum at the ring stage 
were synchronized with 5% sorbitol treatment and the parasites were grown in /// vitro culture 
for about 60 hr. Subsequently the cultures were centrifiiged at 800xg for 10 min and the 
infected red cells were resuspended in the same volume of RPMI-1640 medium containing 
10% normal serum and 100 ^ Ci o f S-methionine (Amerdham, U.K.) per ml of the culture 
medium. The /// vitro culture was further run for 36-48 hr in the candle jar. 
ANTIGEN EXTRACTION 
Antigen from purified P. knowlesi SI-RBCs, P. hiowlesi-SLS, normal rhesus RBC 
ghosts preparation as well as purified '^S methionine labelled-SI-RBC oiP. falciparum from 
iti vitro culture were extracted as described by Kaushal et al. (1983). Briefly 1x10' SI-RBCs/ 
SLS and ghosts from 1x10'^  normal rhesus RBCs, were extracted in 1 ml of extraction buffer 
(containing I%TritonX-100andacocktailofproteaseinhibitors(viz. 1 mMP-chloromercuric 
benzoate(I'CMB), 2 niMphenylmethyl sulphonyl fluoride (PMSF), 0.2 mML-1-tosylamino-
2 phenylethyl chloromethyl ketone (TPCK), 0.2 mM P-tosyl-L-lysine chloromethyl ketone 
TLCK), 10 mM ethylenediamine tetraacetic acid (EDTA) and 1 mM O-phenanthroline) for 
1 hr at 4"C. The extracts were centrifuged at SOOOOxg for 1 hr at 4°C and the supernatant 
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obtained was used as a source of antigen and was kept frozen in small aliquots at 
-70"C until used. 
PROTEIN ESTIMATION 
The protein contents of the tirton extracted antigenic preparations (P. hiowlesi SI-
RBC, P. hiowlesi SLS and rhesus RBC ghosts) were estimated by method of Lowry's et al. 
(1951) as modified by Deans et al. (1978). 
SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS 
The sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed according to the method of Laemmli (1970). Briefly the separating gel (in the 
gradient to 5 to 12.5%) and the stacking gel (3%) were prepared from a stock solution of 
acrylamide (30%) and N,N'-bis methylene acrylamide (0.8%). The samples were prepared 
by mixing antigens {P. hiowlesi SI-RBC/normal rhesus RBC ghosts, ^'S-methionine labelled 
SI-RBC/as well as immune complexes) in 1:1 ratio with sample buffer (containing 0.12M Tris 
HCl, pH 6-8, 2% glycerol, 1% betamercaptoethanol, 5% SDS, 0.002% bromophenol blue) 
and keeping them in boiling water bath for 5 min. The electrophoresis was carried out at room 
temperature in a running butler (containing 0.025 M Iris, 0.192 M glycine (pH 8.3) and 0,1% 
SDS) at a constant current of 15 mA till samples move through the stacking gel and then at 
30 niA until the bromophenol blue dye marker reaches the bottom of the gel. The standard 
proteins of known molecular weight were also run in parallel in order to know the molecular 
weight range of the various proteins present in the samples. After the electrophoresis is 
completed the gels were fixed in 10% trichloroacetic acid. Stain with Commassie blue R-250 
(0.25% w/v in 50% methanol plus 10% acetic acid) and destained with the solution containing 
30% methanol plus 7% acetic acid. In the case of'"^ S methionine labelled antigen and immune 
complex samples, the gel after destaining impregnated with PPO and then dried for 
fluorography (Bonner and Laskey, 1974). 
IMMUNOELECTROPHORESIS 
The immunoelectrophoresis (lEP) was performed according to the method of Graber 
and Williams (1953). Briefly 1.5 thick layer of 1 % (w/v) agarose, prepared in 0.02 M barbital 
buflcr (pi I 8.6) containing I % Triton X-100 (l/IOthofthe volume of agarose), was poured 
on a clean thin glass plate of appropriate size. After setting the agarose, the wells and troughs 
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were cut. The antigens (P. knowlesi SI-RBC/normal rhesus RBC ghosts) were loaded in the 
wells and separated electrophoretically for 1 hr at 10 v/cm. After electrophoresis is 
completed, the immune sera/gamma globulin fraction of immune sera were applied in the 
trough and allowed to react with immune sera for 18-20 hr in a moist chamber at room 
temperature. The plate was then washed three times with isotonic saline by alternate washing 
and pressing under several sheets of filter paper. The last washing was done with distilled 
water. After air drying, the plate was stained with Coomassie blue (0.25% made in 45% 
ethanol and 10% acetic acid) and destaining was done with solution containing 45% ethanol 
plus 10% acetic acid. The formation of precipitin bands were examined in the light. 
CROSSED IMMUNOELECTROPHORESIS 
The crossed Immunoelectrophoresis (CIE) was performed following the method as 
described by Axelsion et al. (1973). Briefly, P. hiowlesi SI-RBC and normal rhesus RBC 
ghost antigens were separated electrophoretically in the first dimension at 10 v/cm in 10% 
agarose for I hr in the same way as described for lEP. Subsequently a longitudinal strip (1 x6 
cm) containing the separated antigens was cut and transferred to another plate (9x6 cm). 
Anodic (5x6x0.12 cm) and cathodic gel (2x6x0.12 cm) gels containing gamma globulin 
fraction of immune sera (5 to 15%) were then poured on the plate. Intermediate gel (1 x6x0.13 
cm) was also poured in between the first and second dimension gels. The electrophoresis was 
then run in second dimension i.e at right angle to the first dimension gel for 18-20 hr by 
employing 2-3 v/cm. After electrophoresis, the plate was washed and stained in the same way 
as described for lEP. The formation of precipitin peaks were observed in the light. The 
optimum concentration of gamma globulin fraction used in the second dimension anodic and 
cathodic gels, is that concentration which gives the maximum resolution of the antigenic 
peaks. 
IMMUNOPRECIPITATION 
Immunoprecipitation was performed as described by Epstein et al. (1981). In order to 
reduce the nonspecific binding of the antigen to the immunosorbent, the 100 ^1 of soluble 
extracts (containing approx 2x 10' cpm) of "S-methionine labelled SI-RBCs were preabsorbed 
with 100 ^l of 50% (v/v) protein-A-sepharose CL-4B gel. 100 nl (1x10* cpm) of this 
preabsorbed antigens was mixed with 100 ^ 1 (1:5 diluted) of malaria (P.falcipanim) patient 
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serum and hyperimmune rabbit serum pools and incubated at 37°C for 1 hr and then 25±2°C 
for 3 hr. Normal human and rabbit sera were used as controls. 100 ^1 (50% v/v of protein-
A sepharose gel were added to the antigen antibody complexes and further incubated at 
25±2"C for 1 hr. The unbound radioactivity was removed by washing twice with NETT buffer 
(composed of 150 mM NaCI, 5 mM EDTA, 50 mM Tris, 0.5% Trion-X-100,0.02% NaN3, 
pH 7.4) containing 10% fetal bovine serum. This is followed by one wash with NETT buffer 
containing 0.5IVI NaCl and 2 washes with NETT buffer alone (gels were spun at 200xg for 
2 min for each wash). The bound radioactivity was counted in a y counter. 
CHAPTER III 
RESULTS fIND DISCUSSION 
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SECTlON-1 
IMMUNOGENICITY AND PROTECTIVE POTENTIAL 
OF PLASMODIUMKNOWLESISCHIZONT INFECTED 
ERYTHROCYTES 
As the clinical symptoms, morbidity and mortality due to malaria in mainly caused by 
the asexual blood stages of malarial parasites, therefore, the antigens associated with the 
asexual blood stages remain the main target for developing vaccine against malaria as well 
as for developing the immunodiagnostic reagents. The protective immunity against asexual 
blood stage antigens derived from avian, rodent, simian and human malaria parasites has been 
demonstrated in suitable experimental hosts by several workers (Zuckerman et ai, 1967a, 
Mitchell et al. 1977b, Siddiqui, 1977, Playfair et al.,\911, Richards et al, 1977, Kilejian, 
1978, Rickman et ai, 1978, Playfair and Desouza, 1986, Kumar, 1990, Patarroyo et al., 
1988). The schizont infected erythrocytes (SI-RBCs) were found to be an excellent source 
for vaccination as these contain antigens both from the merozoite stage as well as the parasite 
infected erythrocytes (Fandeurt?/a/., 1984, Miller e/a/., 1986, Haider t?M/., 1988). So the 
proposed study reported inthis section was undertaken onthe purification oftheP/flsmorfi«m 
knowlcsi schizont infected erythrocytes, its immunogenicity and evaluation of protective 
potential of antibodies. 
1.1 ISOLATION AND PURIFICATION OF 
PLASMODIUM KNOWLESI SCHIZONT INFECTED 
ERYTHROCYTES 
For obtaining the PlasnuxUum knowlesi schizont infected erythrocytes (PK SI-RBCs), 
P. knowlesi infection was maintained in normal rhesus monkeys by injecting intravenously 
1x10" parasited erythrocytes obtained from an infected donor monkey. The patency in 
monkeys was observed on day 5th or 6th and when the parasitaemia reached upto 30-35% 
on day 9lh or JOth, 30-40 ml of infected blood (mainly at schizont stage) was drawn in 
prechilled acid citrate dextrose (ACD). This parasitized blood was washed and passed 
through CF-1 I cellulose column with glass beads on the top. The blood obtained from the 
column was found to be almost free from platelets and leucocytes. For the isolation of 
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P. knowlesi Sl-RBCs, the platelets and leucocytes free infected blood was subjected to one 
step percoll gradient centrifligation as represented diagramatically in Fig. 2. Out of the 
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Fig. 2.Diagrammatic representation of percoll gradient for 
purification of P. knowlest schizont infected-RBCs. 
A - Before centriftigation 
B - After centrilugation 
1 - 15 ml of 40% infected blood + PBS 
2 - 15 ml of 56% Percoll 
3 - PBS 
4 - Dark brown band containing P. knowlesi SI-RBC. 
5 - Uninfected blood. 
different gradients of percoll (40-60%) tried, 56% was found to be most effective for the 
isolation of SI-RBC. The dark brown band at the interface of the 56% percoll was collected 
and it was containing more than 95% pure P. knowlesi Sl-RBCs. The uninfected RBCs pallet 
as well as the immature parasitized RBCs were present at the bottom of the tube. Fig. 3-A 
& B are showing the photographs of the Giemsa stained thin smears of the P. knowlesi 
infected monkey blood and the purified P. knmvlesi Sl-RBCs. These purified P. knowlesi 
Sl-RBCs were found to be biologically active and viable as they were able to invade the new 
erythrocytes in in vitro culture system and also found producing infection when injected to 
normal rhesus monkeys. These purified P. knowlesi Sl-RBCs were stored at -70°C and were 
used in all further experiments. 
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Fig. 3: Photographs showing Giemsa stained thin blood 
smears: 
A - /^ ^//ou/ev/schizont infected monkey blood. 
B - Purified P. hnmlesi schizont infected RBCs 
by percoll gradient (56%) centrifugation. 
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1.2 IIMMIINIZATION OF RABBITS AGAINST P. 
KNOWLESI Sl-RBC AND QUANTITATION OF 
PARASITE SPECIFIC ANTIBODIES IN 
HYPERIMMUNE RABBIT SERA 
Two rabbits (R-1 and R-2) were immunized intramuscularly with P. knowlesi Sl-RBC 
emulsified in Freund' s complete adjuvant over a period of 3 to 4 months. Sera from these 
rabbits were collected separately after each immunization. The gamma globulin (yG) fraction 
was prepared from the immune serum pool (prepared by mixing the immune sera collected 
after IV and subsequent injections) by ammonium sulphate precipitation. The gamma 
globulin fraction obtained was found 3 times concentrated (These immune rabbit sera and 
gamma globulin fraction were stored at -20°C and were used in fiirther experiments for the 
evaluation of protective potential of malarial antibodies in in vitro culture system as well as 
for the characterization of erythrocytic schizont antigens of P. knowlesi). 
The titre values of parasite specific antibodies in immune rabbit sera collected after I 
to VI injections as well as in gamma globulin (yG) fractions of pooled sera were determined 
by employing the techniques of enzyme linked immunosorbent assay and indirect 
haemagglutination assay . 
1.2.1 Enzyme liiiked immunosorbent assay 
Enzyme linked immunosorbent assay (ELISA) was standardized in terms of optimum 
concentration(s) of antigen, antibody conjugate, substrate (0-phenylenediamine) and hydrogen 
peroxide. 
For determining, the optimum concentration of P. knmvlesi SLS antigen, the ELISA 
was done using difl'erent concentrations of antigen (0.0625 to 4 ^g/well) and a fixed dilution 
(1:1000) of anti-P. knowlesi Sl-RBC sera (Sera of VI injection from both rabbits R-1 and 
R-2). The ELISA specific activity (O.D. at 492 nm) obtained are shown in Fig. 4. 1 ^g 
antigen/well corresponding to OD 1.4 (rabbit R-1) and 1.52 (rabbit R-2) was found to be 
optimum concentration as no further increase in the OD was noticed by subsequently 
increasing the antigen concentration upto 4 ng/well, whereas decrease in ELISA values was 
observed on decreasing the antigen concentradon. So in all the fiirther experiments 1 \ig 
P. knowlesi SLS antigen/well was used. 
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Fig. 4: Optimization of P. knowlesi saponin lysed schizont (PK SLS) antigen 
concentration in enzyme linked immunosorbent assay using 1:1000 dilutions 
of rabbit anti-P. knowlesi SI-RBC sera. 
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Fig. 5: Optimization of protein-A-peroxidase conjugate dilution in enzyme linked 
immunosorbent assay using P. knowlesi SLS antigen (1.0 ng/well) at 1:1000 
dilutions of rabbit anti-P. knowlesi SI-RBC sera. 
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For determining the optimum concentration of protein-A-peroxidase conjugate, the 
different dilutions (1 ;500 to 1:4000) of conjugate was tried in ELISA using a fixed dilution 
(1:1000) of hyperimmune anti-P. knowlesi SI-RBC rabbit sera (VI injection sera from rabbit 
R-1 and R-2) and 1 jig/well P. knowlesi SLS antigen. The ELISA specific activity (O.D. 
at 492 nm) recorded are given in Fig. 5. 1:1000 dilution of protein-A peroxidase conjugate 
corresponding to O.D. 1.4 (rabbit R-1) and 1.5 (rabbit R-2) was considered optimum as 
almost the same O.D. (1.43 and 1.51) was noticed at a lower dilution (1:500) of conjugate 
while decrease in ELISA values was observed with the subsequent increase in dilution of 
conjugate. 
The optimum concentration of a 0-phenylenediamine (OPD) was determined using 
different concentration of OPD (0.25 to 2.0 mg/ml) at a fixed dilution (1:1000) of 
hyperimmune anti-F. knowlesi Sl-RBC sera, 1 ng/well of P. knowlesi SLS antigen and 
1:1000 dilution of protein-A peroxidase conjugate. The ELISA values (O.D. at 492 nm) 
obtained are shown in Fig. 6. 1 mg OPD/ml of citrate phosphate buffer, corresponding to 
OD 1.4 (rabbit R-1) and 1,5 (rabbit R-2) was found optimum, as by increasing the OPD 
concentration upto 2 mg/ml, no change in ELISA values was observed and decrease in OPD 
concentration leads to decrease in O.D. value. 
In order to determine the optimum concentration of hydrogen peroxide (H^O )^ for 
colour development, different concentration of H^O^ (0.5 to 4 |jl/ml) were also tried using 
the same dilution (1:1000) of anti-P. knowlesi SI-RBC sera, 1 ng/ well of P. knowlesi SLS 
antigen, 1:1000 dilution of protein-A-peroxidase conjugate, and the ELISA specific dactivity 
(O.D. at 492 nm) was recorded. As shown in Fig. 7, 1 ^l H^O /^ml of substrate solution 
(containing 1 mg OPD/ml) was found to give maximum ELISA specific activity of 1.4 (rabbit 
R-1) and 1.5 (rabbit R-2). The further increase in H^O^ concentration upto 4 ^1/ml results 
in the decrease in ELISA specific activity due to the inhibition in the colour development. The 
lower H ^ , concentration also results in the decrease of ELISA specific activity. Therefore 
1.0 fjl/ml of H,0, was considered optimum. 
Afier optimising the assay conditions of ELISA, the antibody titres of the hyperimmune 
anti-P. knowlesi Sl-RBC sera obtained from the two rabbits (R-1 and R-2) afler different 
injections as well astheir gammaglobulin (YG)fractions(prepared from the pooled sera) were 
determined. All the sera were tested at two fold dilutions starting from 1 ;250 to 1:512000. 
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Fig. 6: Optimization of 0-phenylenediamine (OPD) concentration in enzyme linked 
immunosorbent assay using P. knowlesi SLS antigen (1.0 jig/well) at 1.1000 
dilutions of rabbit anti-P. knowlesi SI-RBCs sera. 
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Fig. 7: Optimization of hydrogen peroxide (H^O )^ concentration in enzyme linked 
immunosorbent assay using P. knowlesi SLS antigen (1 ng/well) at 1; 1000 
dilutions of rabbit anti-P. knowlesi SI-RBC sera. 
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The litre values obtained are given in Fig. 8. The antibody titres were found to be increasing 
till injection IV in case of rabbit R-2 and injection V in case of rabbit R-1. Thereafter it became 
constant at the reciprocal titre value of 128000. The titre value of yG fraction was found to 
be 256000 in case of both the rabbits. 
1.2.2 Indirect haemagglutination assay 
Indirect haemagglutination assay (IHA) was standardized in terms of optimum 
sensitizing concentration of antigen. The glutaraldehyde fixed and tanned sheep erythrocytes 
(SRBCs) were sensitized with different concentrations (2 ng, 1 ng, 0.5 ^g, 0.125 \ig, 0.0625 
Hg per well) of P. knowlesi SLS antigen and IHA was performed using hyperimmune anti-
P. knowlesi Sl-RBC serum collected after VI injection (Reference +ve) and normal rabbit 
serum (Reference -ve). 1 ng P. knowlesi SLS antigen per well was found optimum. The 
results are shown in Fig. 9 and summarized in Table 1. 
Table 1: Optimization of P. knowlesi saponin lysed schizont antigen in indirect 
haemagglutination assay using rabbit anti-P. knowlesi SI-RBC serum. 
S.No. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
IRS: 
MRS 
Antigen 
cone/well (ng) 
0.0000 
0.0625 
0.1250 
0.2500 
0.5000 
1.0000 
2.0000 
Immune rabbit serum 
: Normal rabbit serum 
Reciprocal 
IRS 
0 
400 
800 
1600 
3200 
12800 
12800 
antibody titres 
NRS 
0 
0 
0 
0 
0 
0 
0 
The antibody titres of the anti-P. knowlesi SI-RBC hyperimmune sera from two 
rabbits (R-1 and R-2) collected one week after I to VI injections as well as their gamma 
globulin (yG) fractions were quantitated using the optimal P. knowlesi SLS antigen 
concentration (I ng/well). All the immune sera were tested at two fold dilutions starting from 
1:100. The titre values obtained are shown in Fig. 10 (rabbit R-1) and 11 (Rabit R-2) and 
the results are summarized in Table 2, No antibody could be detected in the sera collected 
< Reciprocal scniiii diititions > 
IRS NRS 
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Fig. 9: Optimization of P. kmnvlesi saponin lysed schizont (PK-SLS) antigen in 
Indirect Haemagglutination Assay (IHA). 
IRS : Immune rabbit serum ; 
NRS : Normal rabbit serum 
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Fig. 10: Antibody litres of rabbit anti-P. hiowlesi SI-RBC sera (rabbit R-1) of different 
injections (I to VI) and y G fraction by indirect haemagglutination assay. 
NRS : Normal rabbit serum 
IRS ; Immune rabbit serum 
Y G : Gamma globulin fraction (prepared from the immune rabbit serum pool) 
Rows 1,2 : No antigen 
Rows 3-12. 1 \igP. knowlesi SLS antigen/well 
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Fig, U: Antibody titres of rabbit &nU-P. hiow/esi SI-RBC sera (rabbit R-2) of different 
injections (I to VI) and y G fraction by indirect haemagglutination assay. 
NRS : Normal rabbit serum 
IRS : Immune rabbit serum 
y G : Gamma globulin fraction (prepared from the immune rabbit serum pool) 
Rows 1.2 : No antigen 
Rows 3-12: 1 ng P. knowlesi SLS antigcn/wcll 
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after 1st injection in case of both the rabbits (R-1 and R-2). The reciprocal antibody titres 
of 800 (rabbit R-1) and 3200 (rabbit R-2) were observed in the sera collected after II injection. 
Subsequently the reciprocal titre value of 3200 was found in case of both the rabbits (R-1 and 
R-2) at 111 injection. After IV injection, the titre values of 6400 (rabbit R-1) and 12800 (rabbit 
R-2) were observed. Thereafter, the titre value became constant at the reciprocal dilution 
of 12800 at Vth and subsequent injection in case of both the rabbits (rabbit R-1 and R-2). 
However, tiie gamma globulin fraction of pooled sera showed an increase reciprocal titre 
value of 25600 in case of both the rabbits. 
Table 2 
S.No. 
1. 
2. 
3, 
4. 
5. 
6. 
7. 
8. 
NRS 
IRS: 
YG : 
: Antibody titres of rabbit anti-P. knowlesi SI-RBC 
indirect haemagglutination assay. 
Sera 
. 
NRS 
IRS (I injection) 
IRS (II injection) 
IRS (III injection) 
IRS (IV injection) 
IRS (V injection) 
IRS (VI injection) 
yG fraction 
sera by 
Reciprocal antibody titres 
R-1 
0 
0 
800 
3200 
6400 
12800 
12800 
25600 
R-2 
0 
0 
3200 
3200 
12800 
12800 
12800 
25600 
: Normal rabbit scrum 
Immmie rabbit sera (collected after I to VI injections from rabbits R-1 and R-2). 
Gamma globulin fractions (Prepared from tlie pooled sera) 
1.3 IN VITRO EVALUATION OF RABBIT ANTl-i? 
KNOWLESI SI-RBC SERA FOR PROTECTIVE 
POTENTIAL OF ANTIBODIES 
1.3.1 In vitro culture of/? knowlesi parasites 
The in vitro culture of P. knowlesi parasites was established using heat inactivated 
normal rabbit sera. The in vi/ro culture was initiated at 0.5% parasitaemia (50 parasitized 
erythrocytes per 10000 erythrocytes) with 95% rings and 5% trophozoites. After 24 hr i.e. 
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after one multiplication cycle, the parasitaemia increased upto 1.66% (1.5% ring +0.16% 
trophozoites) and after two multiplication cycle, 4.7% parasitaemia (4.1% rings + 0.48% 
trophozoites + 0.12% schizonts) was recorded (Fig. 12). This short term in vitro culture of 
P. kn(mlesi parasites was used for testing the effect of immune rabbit sera on multiplication 
of P. knowlesi parasites. 
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Fig. 12: DifTerential cx)unls of rings (R). trophozoites (T) and schizonts (S) of 
P. knowlesi in in vitro culture using 10% normal rabbit serum. 
1.3.2 The effect of immune rabbit sera on multiplication of 
P, knowlesi parasites in in vitro culture system 
To test the effect of immune rabbit sera on multiplication of the parasites, the in vitro 
culture of the P. knowlesi was done for 48 hr in presence of immune rabbit sera obtained from 
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rabbits R-1 and R-2 as well as in normal rabbit sera (control). The parasitaemia increased from 
0.5% to about 4% with normal control sera but no parasite could be detected after 48 hr in 
presence of immune sera from both the rabbits (R-1 and R-2) as well as with immune rabbit 
serum pool (Table 3). 
Table 3: The effect of rabbit anti-P. A«oiv/esiSl-RBC sera on 
P. knowlesi parasites 
Rabbit 
serum 
NRS-1 
NRS-2 
IRS-1 
IRS-2 
IRS-pool 
in in vitro culture. 
% Parasitaemia after 48 hr* 
Exp-1 
4.10 
4.00 
0.00 
0.00 
0.00 
Exp-2 Exp-3 
4.00 4.50 
4.20 4.00 
0.00 0.00 
0.00 0.00 
0.00 0.00 
'Cultures were initiated at approximately 0.5% parasitaemia (mainly ring stage). 
NRS-1 and NRS-2 
lRS-1 and mS-2 : 
IRS-l^ ool was made 
Nonnal sera from rabbit.s R-1 and R-2 
Immune sera from rabbits R-1 and R-2 
by mixing equal 
multiplication of 
MeaniSD 
4.20±0.26 
4.07±0.12 
0.00 
0.00 
0.00 
volumes of two immune rabbit sera (R-1 and R-2) 
DISCUSSION 
For conducting the studies on immunochemical, biochemical, molecular and other 
aspects of malaria, the first and most important requirement is to get the malaria parasites in 
the most purified form at a particular desired stage. The intraerythrocytic development of 
asexual blood stages of malarial parasite and the presence of various other unwanted blood 
components such as platelets and leucocytes complicate the separation of these stages from 
the blood. It has also been reported that during the course of malarial infection, the quantity 
of leucocytes generally increases above the normal value in the peripheral blood circulation 
(Homewood and Neame, 1976). Because of the presence of high level of proteases and other 
degradative enzymes in leucocytes, even a marginal contamination of leucocytes may cause 
a significant variation of the results. Therefore for the authenticity of the data, the removal 
of platelets and leucocytes from the parasite preparation is very essential at the very initial 
stage. Although, the sizeable number of platelets and leucocytes are generally removed 
64 
during the washing of blood while removing the plasma and buffy coats (Zuckerman et al., 
1967a, Beutler, 1971). Among the different methods employed for the complete removal of 
platelets and leucocytes, the columns of glass beads and CF-11 cellulose powder has been 
widely used by number of workers because of its efficiency and simplicity (Schiebel and 
Miller, 1969, Johnson et al., 1980, Richards and Williams, 1973, Williams and Richards, 
1973,HomewoodandNeame, 1976, Howard<?/«/., 1978, Waki and Suzuki, 1986, Goldman 
et al., 1992). In the present study, almost complete removal of platelets and leucocytes from 
the malarial infected blood was achieved by passing the blood through the column of glass 
beads and CF-11 cellulose column. 
Af^ er removing the platelets and leucocytes, the next step is the purification and 
separation of parasitized erythrocytes from the infected blood. As the density of the 
parasitized RBC is lower than the normal RBC, most of the methods employed for isolating 
and concentrating the parasitized from the unparasitized RBCs are based on the differences 
in their densities (Williamson and Cover, 1966, Miller and Chain, 1971,Heidrich, 1988). In 
the present study the percoll density gradient centrifugation method has been employed for 
isolating the P. knowlcsi schizont infected erythrocytes (PK SI-RBCs) from the uninfected 
erythrocytes. More than 95% pure P. hnowlesi SI-RBCs were obtained by employing the 
56% gradient of percoll and the purified SI-RBCs were found morphologically intact and 
completely free from broken Sl-RBC, free parasites, membrane, and early infected erythrocytes. 
They were also found biologically active and viable as they were found invading the new 
erythrocytes in //; vitro culture system and also found producing infection when injected to 
normal rhesus monkeys. Percoll, because of being low viscous, nontoxic, impermeable to 
biological membranes and easily removable has been preferably used as a gradient material 
and has been employed successfully by number of workers for isolating the plasmodial 
infected erythrocytes (Saul et al, 1982, Rivadeneira et al., 1983, Andrysiak et al., 1986, 
Ihalamulla and Mendis, 1987, Haider^/a/., 1988, Handunuettie/a/., 1992). Now for releasing 
the parasites from the infected RBCs, out of the different physical and chemical methods, the 
saponin lysis has been found effective and the most widely used method (Zuckerman e/a/., 1967a, 
Jerusalem and Eling, 1969, Vandyke et al., 1977, Kan and Siddiqui, 1981, Beaumelle, 1987, 
Kiiandc ct al., 1991). So in the present study, the P. kiunvlesi schizonts free from eiythrocytes 
were obtained by lysing the infected erythrocyte suspension with 0.15% saponin. 
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The purified P. knowlesi Sl-RBCs were used to immunize the rabbits and hyperimmune 
sera were raised in order to test the immunogenicity of P. knowlesi SI-RBC, protective 
potential of antibodies and for further characterization of P. knowlesi SI-RBC antigens. In 
the present study, the anti-P. knowlesi SI-RBC sera obtained from two rabbits as well as their 
yG fractions were tested for parasite specific antibodies by employing the techniques of the 
enzyme linked immunosorbent assay (ELISA) and indirect haemagglutination assay (IHA). 
The assay conditions for both the tests were optimized in order to get the optimum resuUs. 
Both the sera (rabbits R-1 and R-2) showed high titres of parasite specific antibodies. In both 
the assays (ELISA and IHA) the increase in titre values with increasing number of 
immunization were observed in case of both the rabbits (R-I and R-2) but the titre values 
become constant after IVth and Vth injections and no increase in titre value were observed 
even after subsequent booster immunization. The antibody titres obtained by ELISA were 
more than those obtained by IHA. The difference in the antibody titres may be due to the 
difference in the sensitivities of these two assays. The ELISA has also been shown to be more 
superior and sensitive than IHA for detecting malarial antibodies by other workers (Mahajan 
t'lal., 198l,Khanna, 1991). 
The immunogenic nature of the erythrocytic stages of different species of malarial 
parasites (rodent, avian, simian and human) has been shown earlier by immunization in 
appropriate experimental animals by different groups of workers (Freunds et al., 1948, 
Targett and Fulton, 1965, Brown etai, 1970a, D'Antonio etai, 1971, Simpson etal., 1974, 
Siddiqui, 1977, Rieckmanf/fl/., 1978, Kaushike/fl/., 1986, Haider^/a/., 1988, Haider, 1990). 
In the present study P. knowlesi schizont infected RBCs were preferred as they are having the wide 
spectrum of antigens associated with intraerythrocytic stages (parasite induced antigens on the 
surface of infected eiythiocytes as well as antigens of the merozoite stage). Although in some 
studies of immunization of rhesus monkeys against P. ktiowlesi (Brown et al., 1970a, Simpson et 
al., 1974, Mitchell etai., 1977a, Kaushik etai., 1986) and owl monkeys against P. falci/xirum 
(Siddiqui, 1977, Mitchell e(al.,\ 977b, Rieckmann et al., 1978), it has been found that both blood 
stage merozoites and schizont infected erythrocytes are equally effective in inducing protective 
immunity. However some other workers have reported that schizont infected RBCs are the most 
potent immunogenic erythrocytic stage in inducing protective immunity (Targett and Fulton, 1965, 
WHO, ]974,Reeset'/a/., 1981). Theantigeniccrossreactivitybetweenthemerozoiteandschizont 
infected RBC of P. ktiowlesi has also been reported (Deans et al, 1978). 
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The presence of protective antibodies in immune rabbit sera was tested by examining 
the effect of immune rabbit sera on multiplication of P. knmvlesi parasites in in vitro culture 
system. The short term //; vilro culture of P. knowlesi was done by candle jar method of 
Trager and Jonsen (1976) separately in presence of normal control and immune (anti-P. 
knowlesi SI-RBC) rabbit sera. Although significant rise of parasitaemia in normal rabbit sera 
were observed while no parasite could be observed in presence of immune rabbit sera. So 
these results suggest the presence of protective antibodies in immune rabbit sera. The //; vitro 
culture assays have also been successfully employed earlier by number of workers for 
evaluating the presence of protective antibodies in immune sera by monitoring their effect on 
multiplication, growth and invasion of malaria parasites (Cohen et al., 1969, Miller, 1975, 
Browne/a/., 1981,Chulaye/a/., 1981a,b,Perrinera/., 1981, Campbell e/a/., 1986,Perlaza 
efal., 1990, Barre/<7/., 1991). 
Therefore, in conclusion, the P. knowlesi SI-RBCs, almost free from platelets and 
leucocytes, were isolated more than 95% pure by employing the column of glass beads and 
CF-11 cellulose and subsequently by applying one step percoll gradient centrifugation. The 
immune rabbit sera raised against these purified P. knowlesi SI-RBCs, showed high litres 
of parasite specific antibodies as quantitated by ELISA and IHA, thus showing the 
immunogenic nature of P. knowlesi SI-RBC. The protective potential of antibodies in 
immune rabbit sera were demonstrated by testing the effect of these immune rabbit sera on 
multiplication of P. knowlesi parasites in /// vitro culture assay. 
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SECTlON-2 
PROTEIN AND ANTIGENIC ANALYSIS OF 
PLASMODIUM KNO WLESI AND PLASMODIUM 
FACLIPARUMSCmZONT INFECTED 
ERYTHROCYTES 
Malaria parasites possess a complex mixture of potentially immunogenic components 
having both species specific as well as common or cross reactive antigens (Eaton and 
Cogshall, 1939, CoW'ms etal., 1966, Deans e/a/., 1978,Kilegian, 1980, Miller e/a/., 1980, 
Kaushal et al, 1990, Moleans and Schoenmakers, 1992). For developing the effective 
malaria vaccine as well as for better immunodiagnostic test, the identification and 
characterization of species specific as well as common or cross reactive antigens between 
different species oiPlasmodium is necessary. Number of techniques based on electrophoresis 
and immunoprecipitation in agar gel system such as SDS-polyacrylamide gel electrophoresis 
(Laemmli, 1970), Immunoelectrophoresis (Graber and Williams, 1953), immunoprecipitation 
of metabolically labelled antigens followed by autoradiography (Epstein et al., 1981) and 
several other immunochemical, biochemical and molecular techniques have been employed in the 
field of malaria immunology for analysing and characterizing the plasmodial antigens. The study 
undertaken in this section is to analyse the protein and antigenic components of Plasmodium 
knowlesi (a simian malaria parasite) schizont infected RBC, and to identify the antigens common 
and cross reactive with P. falciparum (the human parasite) schizont infected RBC. 
2.1 PROTEIN PATTERN OF jR KNWOELSISI-RBC 
The protein patterns of P. knowlesi Sl-RBC and normal rhesus RBC ghosts (for 
comparative purpose) were analysed by SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) after solubilizing them in SOS sample buffer. The standard proteins of known 
molecular weight were also run in parallel for determining the molecular weight range of the 
various proteins present in P. knowlesi SI-RBC. Out of the different concentrations of 
polyacrylamide gel tried, a gradient of 5.0 to 12.5% was found optimum. The number of 
protein bands present in P. knowlesi S\-R^C were found much greater than in normal rhesus 
RBC ghosts. About 30-35 major protein bands in molecular weight range of 15-230 KD were 
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Fig. 13: SDS-poIyacrylamide gel electrophoresis of 
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present in P. knowlesi SI-RBC while only 5-6 bands were obseiA e^d in normal rhesus RBC 
ghosts. The protein stained SDS-polyacrylamide gel electrophoresis pattern of P. knowlesi 
SI-RBC and normal rhesus RBC ghosts is shown in Fig. 13. 
2.2 ANTIGENIC ANALYSIS OF R KNOWLESI SI-RBC 
The antigenic components of P. knowlesi SI-RBC and of normal rhesus RBC ghosts 
(for comparison) were analysed by employing the techniques of immunoelectrophoresis and 
crossed immunoelectrophoresis using anti-/^ knowlesi SI-RBC hyperimmune rabbit sera and 
gamma globulin (yG) fraction of the pooled immune rabbit sera. 
2.2.1 Immunoelectrophoresis 
The antigenic analysis of P. knowlesi SI-RBC and normal rhesus RBC ghosts was done 
initially by immunoelectrophoresis (lEP). The extracts of P. knowlesi SI-RBC and normal 
rhesus RBC ghosts were first separated electrophoretically and then allowed to react with 
anti-P. knowlesi SI-RBC sera collected from two rabbits (R-1 and R-2) after each 
immunization (1 to VI injections). The protein stained lEP patterns obtained are shown 
in fig. 14 and 15 and the resuUs are summarized in Table 4. 
Table 4 
S.No. 
1. 
2. 
3. 
4. 
5. 
6. 
Immunoelectrophoretic analysis 
rabbit sera. 
Rabbit sera 
I injection 
11 injection 
III injection 
IV injection 
V injection 
VI injection 
IRS-l and lRS-2. Immune sera from 
IRS 
PK SI-RBC 
antigen 
0 
5 
8 
10 
12 
12 
rabbit R-1 and R-2 
of P. knowlesi SI-RBC 
No. of precipitin bands 
-1 
Rhesus ghost 
antigen 
0 
1 
2 
3 
3 
3 
using immune 
IRS-2 
PK SI-RBC 
antigen 
1 
6 
10 
12 
12 
12 
Rhesus ghost 
antigen 
I 
2 
3 
4 
4 
4 
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Fig. 14 : Immunoelectrophoretic pattern of P. hiowlesi SI-RBC 
sera obtained after each injection from rabbit R-1. 
A : Normal rhesus RBC ghost antigen 
B : P. hiowlesi SLS antigen 
1 Rabbit anti-rhesus ghost serum 
2 : Rabbit anti-P. hiowlesi SI-RBC serum (pooled) 
3 : Rabbit anti-/^ hiowlesi SI-RBC serum (I injection) 
4 : Rabbit anti-R A7/mi'/e.v/SI-RBC serum (II injection) 
5 Rabbit anti-/^. ^ A?ow/e5/SI-RBC serum(III injection) 
6 : Rabbit anti-P. A7;(7M'/e.v/SI-RBC serum (IV injection) 
7 : Rabbit anti-/^. Arww/t?5/SI-RBC serum(V injection) 
8 : Rabbit anti-P. hiowlesi SI-RBC serum(VI injection) 
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Fig. 15 : Immunoelectrophoretic pattern of P. knawlesi SI-RBC 
sera obtained at\er each injection from rabbit R-2. 
A: Normal rhesus RBC ghost antigen 
B ; P. hwwlesi SLS antigen 
1 : Rabbit anti-rhesus ghost serum 
2 : Rabbit anti-P. knowlesi SI-RBC serum (pooled) 
3 : Rabbit anti-/'. knowlesi SI-RBC serum (I injection) 
4 : Rabbit anti-/^. hiowlesi SI-RBC serum (II injection) 
5 : Rabbit anti-P. hiowlesi SI-RBC serum (III injection) 
6 : Rabbit anU-P. knowlesi SI-RBC serum (IV injection) 
7 : Rabbit anti-P. knowlesi SI-RBC serum (V injection) 
8 : Rabbit anti-P. knowlesi SI-RBC serum (VI injection) 
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Sera from both the rabbits (R-1 and R-2) showed an increase in the number of precipitin arcs 
with increasing number of immunization and a total of 12 precipitin arcs in P. knmvlesi Sl-
RBC were obtained with sera from rabbit R-1 after 5th injection and with rabbit R-2 after 
4th injection. However these immune rabbit sera showed at the most 3-4 precipitin acrs with 
normal rhesus RBC ghost extract. Normal rabbit serum which was used as a control did not 
show any precipitin arc with these antigens. So these results indicate the presence of 8-9 
parasite specific antigens in P. knowlesi SI-RBC. 
2.2.2 Crossed immuiioelectrophoresis 
The antigenic components off*, knowlesi SI-RBC and normal rhesus RBC ghost 
antigens were further analysed by employing the more sensitive technique of crossed 
Immunoelectrophoresis (CIE). Out of the different concentrations (5%, 7.5%, 10% and 
15%) of rabbit anti-F. knowlesi SI-RBC gamma globulin (y G) fractions (prepared from the 
pooled hyperimmune sera of rabbits R-1 and R-2) tried, the better resolution of the antigenic 
peaks was observed with 7.5% y G concentration in case of P. knowlesi SI-RBC and 10% 
y G concentration for normal rhesus RBC ghost antigens. The protein stained CIE patterns 
and their diagramatic representation are shown in figures 16 and 17. In diagram the solid times 
represent the major antigenic peaks and the broken lines represent the minor antigens. 
The CIE analysis revealed 40 preciptin peaks, all of them anodic in P. knowlesi SI-RBC 
(Fig. 16) while only 6 precipitin peaks in normal rhesus RBC ghost extracts (Fig. 17) using 
rabbit anti-P. knowlesi SI-RBC yG fraction. The comparison of the CIE patterns of P. 
knowlesi SI-RBC and normal rhesus RBC ghost antigens (Fig, 16 and 17) indicates the 
presence of 34 parasite specific antigenic components in P. knowlesi SI-RBC. 
2.3 COMMON OR CROSS REACTIVE ANTIGENS OF P. 
KNOhVLESI AND P. FALCIPARUM 
The common or cross reactive antigens between P. falciparum and P. knowlesi were 
analysed by immunoprecipitation of metabolically labelled P. falciparum antigen with 
malaria patient sera (/'. falcipanim) and hyper immune rabbit serum (anti-P. humlesi). 
The malaria {P. falciparum) patient sera collected from State Ayurvedic Medical 
College, Lucknow were tested by IFA for malarial antibodies by employing P. falciparum 
SI-RBC antigen obtained from in vitro culture (Table 5). Three patient serum pools (high, 
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B 
Fig, 16 : Crossed immunoelectrophoretic pattern of P. kiwwiesi SI-RBC antigen using 7,5% 
rabbit anti-/'. kunwiesi SI-RBC gamma globulin fraction 
A •. Protein stained pattern 
B '• Diagrammatic representation 
Solid lines represent strong precipitin peaks while broken lines represent faint peaks. 
Arrows indicate the point of application of antigen 
Anode (+) is to the right in first dimension and to the top in the second dimension. 
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B 
Fig. 17: Crossed immunoelectrophoreticpatternofnormalrhesusRBCghostantigenusing 10% 
rabbit anti-P. hiowesi SI-RBC gamma globulin fraction. 
A : Protein stained pattern 
B : Diagrammatic representation 
Solid lines represent strong precipitin peaks while broken lines represent faint peaks. 
Arrows indicate the point of application of antigen 
Anode (+) is to the right in first dimension and to the top in the second dimension. 
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medium and low titred) were prepared by mixing a group of 5 sera, each having nearly similar 
antibody litres. The reactivity of antibodies present in these serum pools were tested against 
P. falciparum Sl-RBC and P. knowlesi SI-RBC antigen in IFA and the results are given 
in Table 5 and 6. The antibody tires of 12800,1600 and 400 were obtained with P./fl/ci/Mri/m 
SI-RBC while P. knowlesi Sl-RBC gave the titre values of 6400, 800 and 200 respectively 
with the first, second and third serum pools. The hyperimmune rabbit anti- P. knowlesi serum 
showed titre values of 12800 and 25600 with P. falciparum and P. knowlesi SI-RBC 
antigens respectively. 
Table 5: Antibody titres of malaria patient sera in IFA using P. falciparum 
and P. knowlesi antigens. 
Serum No. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
,5. 
1 
Antibody titres 
P.falciparum P. knowlesi 
25600 6400 
6400 3200 
12800 6400 
12800 6400 
6400 3200 
3200 1600 
1600 800 
1600 800 
800 400 
1600 800 
400 200 
400 400 
400 400 
200 200 
200 100 1 
1 
These malaria (P. falciparum) patient serum pools (high, medium and low titred) as 
well as rabbit anti-P. knowlesi serumpool were used to immunoprecipitatethe '^S methionine 
labelled antigens from P. falciparum SI-RBC. The amount of radioactivity immuno-
precipitated with immune sera from P. falciparum were found 14.31%, 12.12% and 3.86% 
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with patient seaim pools 1, 2 and 3 respectively while immune rabbit serum pool (anti-
P. ftMoit'/es/)immunoprecipitated 17.24% radioactivity. The background immunoprecipitation 
with normal serum control was found to be less than 0.5% with both normal human and rabbit 
sera. Results are given in Table 6. 
Table 6: Reactivity of malaria patient {P. falciparum) and hyperimmune rabbit (anti-
P. knowlesi SI-RBC) sera with P. falciparum SI-RBC antigen. 
Sera IFA Immunoprecipitation with 
titres P. falciparum 
Pfalcipanim P.hiowlesi CPM bound % Binding 
Patient serum (P.f): 
Pool-1 (High) 12800 6400 7158 14.31 
Pool-2 (Medium) 1600 800 6104 12.21 
Pool-3(Low) ._ 400 200 1932 3.86 
NHS - - 187 0.37 
IRS (anti-P.k) Pool 12800 25600 8620 17.24 
NRS . - - 159 0.32 
Scnuii pool.s 1,2 and 3 were prepared by mixing sera (100 jil) each from patient serum No. 1 to 5 (liigh titred), 
6 to 10 (medium titred) and 10 to 15 (low titred) respectively. The IFA titres of these individual 15 sera are 
given in lable 5. 
NHS : Normal human serum. 
IRS : Immune rabbit serum. 
NRS : Nonniil rabbit .senini. L 
The ^ 'S-methionine labelled proteins oiP. falciparum after immunoprecipitation were 
analysed on SDS-PAGE and the tluorogram is shown in Fig. 18. 10-12 antigens in P. 
falciparum SI-RBC were recognized by the first (high titred) and the second (medium titred) 
serum pools while the third (low titred) serum pool recognized 4-5 antigens in P. falciparum. 
The rabbit anti P. knowlesi hyperimmune serum recognized 15-16 antigens in P. falciparum 
SI-RBC. I'ive major antigens of 195, 120, 97, 94 and 74 KDs were found to be common 
or cross reactive between the P. falciparum and P. knowlesi as these antigens were 
recognized by both patient sera {P. falciparum) and immune rabbit serum (anti-P. hiowlesi). 
The 74 KD antigen was most strongly recognized by all the immune sera (Table 7). 
1 1 • 
TOP 
200 
Fig. 18: SDS-PAGE and fluorographic analysis of "S-
methionine hheWtA P. falciparum SI-RBC antigen 
immunoprecipitated with malaria patient sera {P. 
falciparum) and hyperimmune rabbit serum (anti-
P. hiowlesi). 
A ; Totel antigen 
Immune rabbit serum (anti-P. hiowlesi) 
Normal rabbit serum 
Patient serum pool-1 (high titred) 
Patient serum pool-2 (Medium titred) 
Patient serum pool-3 (Low titred) 
Normal human serum 
The IF A titres and CPM immunoprecipitated by 
these serum pool are given in Table 6. 
TOP is the point of application and BOB is 
bromophenol blue dye marker. 
B 
C 
D 
E 
F 
G 
^^••J:i'V'f^^-< M: 
^ , . 1 ^ 6 3 ^ ,^ 
78 
Table?. Common or cross reactive antigens between P.falciparum and 
R knowlesi SI-RBCs immunoprecipitated with malaria patient sera 
{P. falciparum) and hyperimmune rabbit serum (anti-P. knowlesi Sl-
RBC). 
Antigens 
Mol. wt.(KD) 
195 
120 
97 
94 
74 
Recognition with immune sera 
Patient sera 
{P.falciparum) 
+ 
+ 
+ 
+ 
++ 
Hyperimmune rabbit serum 
{Bn\\-P.hwwlesi) 
+ 
+ 
+ 
+ 
++ 
DISCUSSION 
This section deals with the analysis of protein and antigenic patterns of P. knmvlesi SI-
RBC as well as common or cross reactive antigens between P. knowlesi and P. falciparum 
SI-RBCs. The protein pattern of P. knowlesi SI-RBC was analysed by employing the 
technique of SDS-polyacrylamide gel electrophoresis (SDS-PAGE). The normal rhesus 
RBC ghost antigen was used for comparison. Out of the different concentrations of 
polyacrylamide tried, the best resolution of proteins was achieved using 5-12% polyacrylamide 
gradient. The SDS-PAGE revealed 30-35 major protein bands in the molecular weight range 
of 15-230 KD in the case of P. knowlesi SI-RBC. The number of protein bands present in 
P. knowlesi S l-RBC were found much greater than the normal RBC ghost. The SDS-PAGE 
provides the high resolution of proteins on molecular weight basis and the technique has been 
employed widely for analysing the protein pattern of variety of parasites (Miller et ai, 1980, 
KaushaUra/., 1982, 1988, Carlssone/a/., 1984; Anders, 1985, Singh e/a/., 1986, Mohen 
et ai, 1988). The immunoprecipitation techniques in agar gel system provide an easy basis 
for quantitative analysis of the antigenic components of pathogens using their corresponding 
antisera. In the present study, the techniques of immunoelectrophoresis (lEP) and crossed 
immunoelectrophoresis (CIE) were used to analyse the antigenic components of P. knowlesi 
SI-RBC and normal rhesus RBC ghost (for comparative purpose) using rabbit anti-P. 
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knowlesi SI-RBC sera. The increase in precipitin arcs with increasing number of immunization 
were observed in case ofboth the rabbit sera upto injections IV and V and thereafter it became 
constant. The lEP analysis revealed the presence of 12 precipitin acrs in P. knmvlesi SI-RBC 
while only 3-4 precipitin acrs were observed with normal rhesus RBC ghost, thereby 
suggesting the presence of 8-9 parasite specific antigens in P. knmvlesi SI-RBC. The lEP 
techniques has also been employed by earlier workers for the antigenic analysis of malaria 
parasites (Spira and Zuckerman, 1962, Sherman, 1964, Zuckerman, 1964, Zuckerman and 
Spira, 1965, Singh era/., 1986, KaushaU/a/., 1988, Haider, 1990). 
The antigenic components of P. knowlesi SI-RBC and normal rhesus RBC ghost (for 
comparison) were further analysed by employing the more sensitive technique of crossed 
Immunoelectrophoresis (CIE) i.e. two dimensional immunoelectrophoresis using rabbit anti-
P. knowlesi gamma globulin fraction. Out of the different concentration of gamma globulin 
(yG) fraction tried in the second dimension gel, the sharp and balanced pattern of precipitin 
peaks were obtained with 7.5% concentration of yG fraction in case of P. knowlesi SI-RBC 
while a 10% concentration of yG fraction was found optimum in the case of normal rhesus 
RBC ghosts. The lowering of the yG concentration resulted in the disappearance of some 
of the faint peaks while increasing the concentration upto 15% caused the overlapping and 
the poor resolution of some of the closely placed antigenic peaks. A carefijl examination of 
CIE pattern revealed the presence of 40 antigenic peaks (all of them anodic) in P. knowlesi 
SI-RBC while only 6 antigenic peaks were observed in normal rhesus RBC ghost extract thus 
suggesting the presence of 34 parasite specific antigens in P. knowlesi SI-RBC. The 
technique of CIE has also been employed earlier by number of workers to analyse the 
antigenic component of malaria and other parasites (Butcher et al., 1978, Miller et al. ,1980, 
Kaushal £'/«/., 1982, Panton <?/«/., 1984a, b, Anders, 1985, Cavlan e/o/., 1985, Malhotra 
et al., 1986, Mohan el al., 1988, Haider, 1990). By employing the techniques of 
immunoelectrophoresis. Deans el al. (1978) have identified 11 major parasite specific 
antigens in P. knowlesi SI-RBC using monkey anti merozoite serum. Carlsson et al. (1984) 
have analysed P. chabaiidi and P. yoelii infected erythrocytes using rabbit antisera in CIE and 
observed 12 antigenic peaks in both the parasites. Kaushal et al. (1988) have reported the 
antigenic analysis of P. cynomolgi SI-RBC by employing the technique of CIE using monkey 
antiserum and showed the presence of 27 antigenic components in P. cynomolgi SI-RBC. 
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In the earlier studies on antigenic characterization of malarial parasites, it has been 
shown that malarial parasites are having both species specific as well as common or cross 
reactive antigens betwen different species of malarial parasites (Collins et al., 1966, Deans 
eta/., 1978, Haton and Cogghsall, 1939, Kilejain, 1980, MiWer etal., 1980, Moleans and 
Schoenmakers, 1992). In view of cross reactivity that exist between different species of 
malaria parasites, the crude antigenic preparation from simian malarial parasites such as P. 
yt/7oii'/t'.v/(VoIlerandO'Neil 1971, Voller<.'/«/., 1975, Agarwal c/a/., 1981, MahajanWr//., 
1981, Dutta et al., 1982) and P. cyuomolgi (Dutta et al, 1984) have been used for the 
serodiagnosis of human malaria. P.falcipanim antigen obtained from /// vitro culture has also 
been used for the detection of antibodies against P. vivax in patient sera (Kumar et al., 1992). 
In the present study common or cross reactive antigen between P. knowlesi and P. 
falciparum Si-RBCs were identified by immunoprecipitating the metabolically ('"^ S-
methionine) labelled P. falciparum SI-RBCs with immune sera from patients having P. 
falciparum infection as well as the hyperimmune rabbit serum against P. knowlesi SI-RBCs. 
The immune serum pools (high, medium and low titred), instead of individual serum, were 
used so as to include the widest spectrum of antibodies induced during the malarial infection. 
The results indicate the existence of high degree of cross reactivity between P. knowlesi and 
P. falciparum SI-RBCs both by IFA and immunoprecipitation. However, the reactivity of 
antibodies present in the patient sera were found more with homologous {P. falciparum) 
antigens as compared to heterologous {P. hiowlesi) antigens. The superiority of homologous 
antigens over heterologous antigens has also been reported by earlier workers (Diggs and 
Sadun, 1965, Collins etal, 1966, Ungureanu etai, 1980, Bhatt and Srinivasa, 1983). 
The immunoprecipitation and SDS-PAGE analysis of the ^^S-methionine labelled 
proteins of P. falciparum Sl-RBC revealed that 10-12 antigens were recognized by the first 
(high titred) and second (medium titred) patient serum pools, 4-5 antigens by the third serum 
pool (low titred) while hyperimmune rabbit serum pool (anti-P. hicM'lesi) recognized 15-16 
antigens in P. falciparum The comparative evaluation of P. falciparum antigens 
ininumoprccipitalcd by paticiU scium \woh and iininunc rabbit seium pool revealed that 5 
major antigens of 195, 120, 97, 94 and 74 KD are common or cross reactive between these 
two parasites. As indicated in the results one common antigen of 74 KD was most strongly 
recognized by all these sera In earlier studies the existence of common antigenic 
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determinants on the surface of/^ knowlesi merozoite and P. falciparum schizonts has also 
been reported (Miller ^M/., 1980). The three interspecies plasmodial antigens between 
P. knowlesi and P. falciparum were identified on the surface of the schizont infected 
erythrocytes (Schimidt-Ullrich et al., 1982). The potential of 74 KD protein of P. knowlesi 
and P. falciparum has also been shown by earlier workers to induce protective immunity. 
Sera from monkeys immunized against this antigen immunoprecipitated the 74 KD protein 
from both P. knowlesi and P. falciparum. The 80% tryptic peptide homology in this 74 KD 
proteins from both the species of malaria parasites has also been reported. Additional 
evidence for sharing of important epitopes on the 74 KD protein of these two parasites 
emerged from the antibody mediated blockage of//f vitro growth (WHO, 1984, Schmidt-
Ullrich t?/a/., 1986b). 
Therefore in the present study, the SDS-PAGE analysis of P. knowlesi Sl-RBC 
revealed the presence of 30-3 5 major protein bands while only 5-6 bands were found in nomral 
rhesus RBC ghosts. The immunoelectrophoretic analysis revealed the presence of 34 parasite 
specific antigens in P. A/ioit'/ev/ Sl-RBC. Theimmunoprecipitation and SDS-PAGE analysis 
of "S-methionine labelled antigens of P. falciparum SI-RBC with patient sera {P. 
falciparum) and immune rabbit serum (P. knowlesi) revealed the presence of 5 common or 
cross reactive antigens (195,120,97, 94 and 74 KD) between these two parasites, of these 
the 74 KD antigen was found to be major common antigen. 
CHAPTER IV 
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SUMIVIARY & CONCLUSIONS 
Malaria is a parasitic infection caused by a protozoan parasiteofthegenus7Va5/;7(W/?//;;, 
which undergoes a complex multistage developmental cycle that alternates between a 
vertebrate and an invertebrate vector host, the female anopheles mosquito. Despite the 
continuous efforts and major eradication programmes of WHO, malaria still remains one of 
the major world heatlh problems and the greatest killer of mankind particularly in the tropical 
and subtropical regions ofllie world. I'oi a bi iefperiod in early 1960s it appeared that malaria 
might soon be brought under control. Extensive spraying of dichlorodiphenyl trichloroethane 
(DDT) greatly helped in reducing anopheline mosquito population while effective 
chemotherapeutic measures were equally successful in controlling the disease. A few novel 
drugs such as chloroquine and mefloquine were successfully used for treating the patients. 
But ten years later by the mid 1970s with the resurgence of malaria, the situation was entirely 
different, the chlorinated insecticides, such as DDT, were proving to be ineffective due to a 
newly acquired phenomenon, the insecticidal resistance in mosquitoes and a more alarming 
situation has arisen due to acquired resistance in Plasmodium falciparum to various anti-
malarial drugs. Currently this constitutes the most important threat towards our efforts for 
effective control of the disease. Chloroquine and multiple drug resistant strains of P. 
falciparum are spreading in various regions of the world including India. So in view of this 
grim situation it seems that the repertoire of tools and methods available for malaria control 
are not keeping pace with the increasing complexity of the disease over the last three decades. 
The failure ofthe conventional measures to control and eradicate malai iahas led the scientists 
and research organisations to the revival of their interest in malaria research not only for finding 
the better chemotherapeutic measures but also towards finding an immunological solution to the 
disease. The development of malaria vaccine and the better immunodiagnostic methods still remain 
the two main objectives ofthe scientific working groups ofthe WHO on immunology of malaria 
since it was set up in 1976. Although, significant advanceshavebeenmadeindevelopingthe vaccine 
against different developmental stages ofthe malarial parasites viz. sporozoite stage, asexual blood 
stages as well as gametocyte stages,tlie slow progress ofthe malaria vaccine development may be 
attributed to the complex multistage developmental cycle ofthe parasite and the nature of its 
interaction with its host as well as lack of suitable animal model for human malaria parasites. 
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As the morbidity, its clinical symptoms and mortality due to malaria is mmnly caused 
by the asexual blood stages, therefore,the blood stages of malaria parasite remains the main 
focus of malaria research not only for developing the new antimalarial drugs but also for 
developing the antimalarial vaccine, as wellasforimmunodiagnostictest. The biological and 
morphological similarities between human and nonhuman primate malarias make the later 
good animal model for human malaria providing suitable laboratory host available. Therefore 
the proposed study reported in this thesis deals with the immunochemical studies on asexual 
blood stages of primate malaria parasites, P. knowlesi (a simian malaria parasite) and P. 
falciparum (the most dreaded of human malaria), in order to identify the common or cross 
reactive antigens between these two parasites. So the information obtained from the 
proposed study may be useful and may fUrther be explored for developing better 
immunodiagnostic test and immunoprophylactic measures of human malaria. 
The studies were initiated with the purification of P. knmvlesi schizont infected RBCs 
(SI-RBCs), which were purified more than 95% (free from platelets and leucocytes) using 
CF-11 cellulose' and glass beads column followed by one step percoll gradient (56%) 
centrifugation. The purified SI-RBCs were found to be intact and completely free from 
broken SI-RBCs, free parasites, membranes and the early infected erythrocytes. These 
purified P. knowlesi SI-RBCs were also found biologically active and viable as they were 
able to produce infection when inoculated in monkeys and they were also found invading 
the RBCs in in vitro culture system. 
The purified P. knowlesi SI-RBCs were used to immunize the rabbits for raising the 
polyvalent hyperimmune serum. Two rabbits were immunized over a period of 3-4 months. 
The immune rabbit sera collected after each injection (from I to VI injections) as well as their 
yG fractions (prepared 3 times concentrated from pooled immune rabbit sera by ammonium 
sulphate precipitation) were tested for the parasite specific antibodies by employing the 
techniques of enzyme linked immunosorbent assay (ELISA), indirect haemagglutination 
assay (IHA). In both these assays, an increase in titre values with increasing number of 
immunization were observed in case of both the rabbits, however, the titre values became 
constant after IV and V injections. The ELISA was found more sensitive than IHA. The 
maximum values of reciprocal antibody titre were found 128000 as determined by ELISA 
and 12800 by IHA in the immune rabbit sera collected after IV and subsequent injections in 
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case of both the rabbits, however, the yG fractions of the pooled immune sera gave the 
increased values of reciprocal antibody titre of 256000 (by ELISA) and 25600 (by IHA) in 
case of both rabbits. 
The presence of protective antibodies in immune rabbit sera was demonstrated by 
examining their effect on multiplication of P. knowiesi parasites in in vitro culture system. 
The short term //; vitro culture of P. knowiesi was done by candle jar method of Trager and 
Jensen (1976), separately in the presence of normal control and immune (anti-P. knowiesi 
SI-RBC) rabbit sera. Though significant rise of parasitaemia in normal rabbit sera was 
observed while no parasites were observed in presence of immune rabbit sera. Therefore, 
these results indicated the presence of protective antibodies in immune rabbit sera. 
In subsequent studies, the protein and antigenic components of P. knowiesi SI-RBC 
were analysed by employing the techniques of SDS-poIyacrylamide gradient gel electrophoresis 
(SDS-PAGE) and immunoelectrophoretic techniques. The normal RBC ghost antigenic 
extract was also analysed alongwith for comparative purpose. The SDS-PAGE resolved the 
P. knowiesi SI-RBC into 30-35 major protein bands in the mol. wt. range of 15-230 KD on 
5-12% gradient of polyacrylamide. The number of protein bands present in P. knowiesi SI-
RBC were found much greater in number as well as having several additional and heavily 
stained protein bands than that in normal rhesus RBC ghost, thereby indicating certain 
qualitative and quantitative ditTerences in the protein patterns of P. knowiesi SI-RBC and 
normal RBC ghost. 
The antigenic components of P. knowiesi SI-RBC were analysed initially by employing 
the technique of immunoelectrophoresis (IE?) using rabbit anti-P knowiesi SI-RBC sera. 
The lEP analysis showed an increase in the number of precipitin arcs with increasing number 
of immunization. The number of precipitin arcs become constant at 12 with sera obtained 
after IV and V injections However, only 3-4 precipitin arcs were formed with normal rhesus 
RBC ghost antigen against rabbit anti-P. knowiesi SI-RBC sera. So these results indicated 
the presence of 8-9 parasite specific antigens in P. knowiesi SI-RBC. 
The antigenic components of P. knowiesi SI-RBC and normal rhesus RBC ghost were 
further analysed more clearly by employing the more sensitive technique of crossed 
immunoelectrophoresis (CIE) using rabbit anti-P. knowiesi SI-RBC gamma globulin 
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fraction (yG, prepared from the pooled hyper immune rabbit sera). Out of the different 
concentrations(5%, 7.5%, 10% and 15%)of gamma globulinfraction tried, better resolution 
of antigenic peaks was observed with 7.5% gamma globulin concentration with P. knowlesi 
SI-RBC and 10% gamma globulin concentration with normal rhesus RBC ghost antigens. 
The CIE analysis revealed 40 antigenic peaks with P. knowlesi SI-RBC while only 6 
antigenic peaks were observed with normal rhesus RBC ghost antigens, thereby suggesting 
the presence of 34 parasite specific antigens in P. knowlesi SI-RBC. 
In order to focus attention on the common or cross reactive antigens between 
P. knowlesi and P. falciparum SI-RBCs, the triton extracts of the ''S-methionine labelled 
SI-RBC o^P. falciparum were immunoprecipitated with immune sera from patients having 
malaria {P. falciparum) infection and rabbit ?Lni\-P.hiowlesi SI-RBC hyperimmune sera. The 
immune complexes formed were further analysed on SDS-PAGE followed by autoradiography. 
Instead of individual patient sera, immune serum pools (high, medium and low titred) were 
used for inimunoprecipitalion so as to include the widest spectrum of antibodies. The 
antibody titres of individual patient sera as well as immune serum pools were quantitated by 
IFA using P. falciparum SI-RBC as well as P. knowlesi SI-RBC antigens. The antibody 
titres were obtained more with P. falciparum SI-RBC as compared to P. knowlesi SI-RBC. 
The '"^S-methionine labelled proteins of P./rt/ci/;rtri//« after immunoprecipitation were 
analysed on SDS-PAGE, which revealed that 10-12 antigens were recognized by patient sera 
{P. falcipanim) while 15-16 antigens were recognized by hyperimmune rabbit sera (anti-P. 
knowlesi SI-RBC). On comparing, 5 major antigens of 195, 120, 97, 94 and 74 KD were 
found to be common or cross reactive between these two parasites, one common antigen of 
74 KD was found most strongly recognised by all the three patients serum pools as well as 
hyperimmune rabbit serum. 
In conclusion, we have been able to purify P. knowlesi SI-RBC more than 95% (free 
from platelets and leucocytes) using glass beads and CF-11 cellulose column and subsequently 
by applying one step percoll gradient centrifijgation. Immune rabbit sera raised against 
P. knowlesi SI-RBC showed high titres of parasite specific antibodies, as detected by 
(ELIS A) and (IHA), thus showing the immunogenic nature of P. knmvlesi SI-RBC. These 
hyper iniMuinc rabbit anti-P. knowlesi SI-RBC sera were found to contain protective 
antibodies, as they inhibited the multiplication of P. knowlesi parasites in in-vilro culture. 
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Thse SDS PAGE analysis of P. knowlesi Sl-RBC revealed the presence of 30-35 major 
protien bands in the molecular weight range of 15-230 KD. The immunoelectrophoretic 
analysis revealed the presence of 34 parasite specific antigens in P. knowlesi Sl-RBC. The 
immunoprecipitation and SDS-PAGE analysis of "S- methionine labelled antigens of P. 
falciparum Sl-RBC with malaria (P. falciparum) patient sera and hyper immune rabbit sera 
(anti-P. knowlesi Sl-RBC) pools revealed the presence of 5 common or cross reactive 
antigens of mol. wts. 195, 120, 97,94 and 74 KD between these two parasites, of these, the 
74KD antigen was found to be a major common antigen. 
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